Halozyme experts will participate in 3 panel discussions at #podd2026 on Oct. 30.
1) targeted drug conjugate delivery 2) formulation approaches to reduce patient burden 3) next-generation coformulation and device development for combination therapies.
Hope to see you there!
Halozyme
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. More on Wikipedia
-
Halozyme, Inc.
@halozymeinc
-
Halozyme, Inc.
@halozymeinc
Halozyme is proud to be an Executive Sponsor of #podd2026.
Join Chief Scientific Officer Chris Wahl, MD, MBA, for "Advancements in High-concentration, High-Dose Formulations for SC Administration of Protein Therapeutics."
Oct. 29 | 6:15 p.m. ET | Boston
#drugdelivery #halozyme -
Halozyme, Inc.
@halozymeinc
See Halozyme's Chris Wahl, MD, MBA, at #aaps360 for the Hot Topic session "From Viscosity to Stability: Formulation Technologies for Concentrated Biologics."
Oct. 28 | 2:30 p.m. CT | New Orleans
#biologics #drugdelivery #halozyme -
Halozyme, Inc.
@halozymeinc
Halozyme reported record Q2 2026 results, with total revenue of $481M (+48% YoY) and royalty revenue of $308M (+50% YoY). The company also raised its full-year 2026 financial guidance and has signed 5 new collaboration agreements YTD. shorturl.at/CbweQ
-
Halozyme, Inc.
@halozymeinc
Halozyme will release second quarter 2026 financial and operating results on 8/6, following the close of trading. We will host a conference call at 1:30pm PT/4:30pm ET to discuss the results. The call can be accessed live via this link: events.q4inc.com/analyst/838122249?pwd=X5tkHKiy
-
Halozyme, Inc.
@halozymeinc
Looking ahead to #crs2026:
David Kang and Chris Wahl will participate in:
Workshop: Advancing Technologies & Strategies for SC Drug Delivery (July 6, 12:30–4:30) with talks at 1:25 PM & 3:35 PM
as well as a session on Nanomedicine and Nanoscale Delivery XI (July 9, 2:30–4:30 PM) -
Halozyme, Inc.
@halozymeinc
Halozyme and Oruka entered a global exclusive collaboration and license agreement for use of Halozyme’s Hypercon™ technology with ORKA‑001, in development for psoriasis and related inflammatory diseases, and up to one additional target.
Learn more: ir.halozyme.com/news/news-details/2026/Halozyme-and-Oruka… -
Halozyme, Inc.
@halozymeinc
Halozyme announced a global exclusive collaboration with Vertex Pharmaceuticals to license its Hypercon™ technology for up to three drug targets. Read more here: ir.halozyme.com/news/news-details/2026/Halozyme-Announces…
-
Halozyme, Inc.
@halozymeinc
Halozyme reported record FY2025 results:
• Revenue up 38% to $1.4B
• Royalties up 52% to $868M
Driven by ENHANZE®, partner launches & our expanded drug delivery portfolio.
We’re reiterating strong 2026 guidance ($1.71–$1.81B revenue) with royalties expected to exceed $1B. -
Halozyme, Inc.
@halozymeinc
Halozyme acquires Surf Bio, raises 2025 revenue estimates and increases 2026 & multi‑year guidance.
More here: ir.halozyme.com/news/news-details/2026/Halozyme-Raises-20… -
Halozyme, Inc.
@halozymeinc
Halozyme will host an Investor Conference Call on Jan 28 at 5:30am PT / 8:30am ET.
Dr. Helen Torley (CEO) and Nicole LaBrosse (CFO) will share preliminary FY25 revenue results, updated 2026–2028 financial guidance, and a business update.
Register: registrations.events/direct/Q4I1205969 -
Halozyme, Inc.
@halozymeinc
We have entered a global collaboration with Takeda to provide access to our drug delivery technology for use with its Crohn’s and ulcerative colitis biologic therapy.
Read more: ir.halozyme.com/news/news-details/2026/Halozyme-Announces…
#ibd #crohnsdisease #ulcerativecolitis #drugdeliveryinnovation -
Halozyme, Inc.
@halozymeinc
Halozyme and Skye Bioscience announce a global collaboration to evaluate nimacimab co-formulated with ENHANZE® for obesity, supporting higher-dose subcutaneous administration strategies. Details: ir.halozyme.com/news/news-details/2026/Halozyme-and-Skye-…
#halozyme #skyebioscience #enhanze #obesityresearch -
Halozyme, Inc.
@halozymeinc
The U.S. FDA has approved @JNJNews new subcutaneously administered therapy for the treatment of EGFR-mutated advanced NSCLC in adults. Co-formulated with our drug delivery technology, it has the potential to offer more personalized care.
ir.halozyme.com/news/news-details/2025/U-S--FDA-Approves-… -
Halozyme, Inc.
@halozymeinc
Halozyme has completed the acquisition of Elektrofi, adding Hypercon™ ultra-high concentration technology to our drug delivery portfolio.
This milestone expands our ability to make treatments fit seamlessly into patients’ lives.
Learn more: www.prnewswire.com/news-releases/halozyme-completes-acqui… -
Halozyme, Inc.
@halozymeinc
Merus and Halozyme have entered a global collaboration to develop a subcutaneous formulation of petosemtamab using Halozyme’s ENHANZE® technology – aiming to improve treatment efficiency and patient experience.
Learn more: ir.halozyme.com/news/news-details/2025/Merus-and-Halozyme…
#drugdelivery #innovation -
Halozyme, Inc.
@halozymeinc
Halozyme Delivers Strong Q3 2025 Results — Raises Full-Year Guidance
We reported another quarter of robust growth, view the full press release here: ir.halozyme.com/news/news-details/2025/HALOZYME-RAISES-20…
#halozyme #q3results #investorrelations #biotech #financialperformance #growth -
Halozyme, Inc.
@halozymeinc
One week to go! We’re headed to #pdauniverse in Vienna, Oct 21–22 — find us at Booth 18 or presenting!
Explore our portfolio of auto-injectors, including the HVAI™ — designed for subcutaneous delivery of large-volume biologics.
Want to meet? Drop us a comment! -
Halozyme, Inc.
@halozymeinc
We’re heading to Fierce Biotech Week!
Dr. Helen Torley, CEO & President
Oct 7 | 3:45–4:15 PM
"The Future, Under Your Skin – Why Subcutaneous Tech is the Next Frontier in Medicine”
Dr. Charles Theuer, CMO
Oct 8 | 2:45–3:30 PM
"Formulation & Innovation for Next-Gen Therapies" -
Halozyme, Inc.
@halozymeinc
We kicked off our annual #stjude fundraiser with a picnic and a bold goal:
25M steps
$25K raised
We’re proud to support St. Jude Children's Research Hospital, where families never receive a bill for care. Follow our journey as we walk, run & roll together! #oneteam -
Halozyme, Inc.
@halozymeinc
New publication in the Journal of Controlled Release:
"An industry perspective on clinical development and regulatory strategies for subcutaneously administered high-dose biologics"
Co-authored by Halozyme and peers from the SC Drug Delivery Consortium.
www.sciencedirect.com/science/article/pii/S0168365925007680 -
Halozyme, Inc.
@halozymeinc
Our VP of Corporate Communications & IR will be hosting 1x1 investor meetings tomorrow at the H.C. Wainwright 27th Annual Global Investment Conference in NYC.
Sept 9, 2025
1x1 Meetings
New York, NY
#investorrelations #hcwainwright #ir #nyc -
Halozyme, Inc.
@halozymeinc
Our CEO, Dr. Helen Torley, will join the Morgan Stanley 23rd Annual Global Healthcare Conference for a fireside chat + 1x1 investor meetings.
Sept 8, 2025
4:45am PT / 7:45am ET
NYC
Webcast: ir.halozyme.com/events-and-presentations/default.aspx
#halo #biotech #healthcareleadership #investorrelations -
Halozyme, Inc.
@halozymeinc
We’re excited to share that our President & CEO, Dr. Helen Torley, will join the 2025 Wells Fargo Healthcare Conference this week in Boston!
Sept 4 | 10:30am PT / 1:30pm ET
Fireside Chat + 1x1 Investor Meetings
Learn more: ir.halozyme.com/news/news-details/2025/Halozyme-to-Partic… -
Halozyme, Inc.
@halozymeinc
One Team, Big Impact!
Our 2025 Dedicated Service Time brought employees together to support 8 incredible orgs - packing meals, making blankets, clearing trails & more.
Thank you to everyone who gave their time & heart!
#oneteam #communityimpact #volunteering #makingadifference -
Halozyme, Inc.
@halozymeinc
New research alert!
Our experts co-authored a study on a rapid high-volume AI (HVAI) that can deliver 10 mL in 30 s to administer therapeutics co-formulated with a proprietary recombinant human hyaluronidase PH20 (rHuPH20).
doi.org/10.1007/s13346-025-01883-z
#drugdelivery #biotech -
Halozyme, Inc.
@halozymeinc
Halozyme reports strong Q2 2025 results and raises full-year guidance
Revenue: $326M (+41% YOY)
Royalty: $206M (+65%)
Net Income: $165M (+77%)
EPS: $1.33 GAAP / $1.54 Non-GAAP
Adj. EBITDA: $226M (+65%)
2025 guidance raised + new $250M share repurchase -
Halozyme, Inc.
@halozymeinc
Join us at #pda Miniverse 2025 in Indianapolis, June 25–26!
David Kang, Director of Drug Delivery, speaks on:
High-Dose High-Volume SC Delivery: Trends & What’s Next
June 26 | 10:30 AM–12:00 PM CT
Session P6: Big Shots – The Future of LV Systems
#drugdelivery #subcutaneous -
Halozyme, Inc.
@halozymeinc
🌍 Happy Earth Day! 🌍 At Halozyme, we prioritize sustainable operations to create lasting value for our stakeholders. Today, we reaffirm our commitment to a greener future. Discover our ESG strategy in our latest report: halozyme.com/wp-content/uploads/HALO-ESG-2024-FINAL-v1.pdf #earthday2025 #sustainability #esg
-
Halozyme, Inc.
@halozymeinc
Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the TD Cowen 45th Annual Healthcare Conference on Wednesday, March 5 at 8:50am PT / 11:50am ET.
A live audio webcast will be available here: wsw.com/webcast/cowen177/register.aspx?conf=cowen177&page… -
Halozyme, Inc.
@halozymeinc
Exciting news! We achieved record revenue in 2024. Highlights:
Total revenue: $1.015B (+22% YOY)
Royalty revenue: $571M (+27% YOY)
Net income: $444M (+58% YOY)
GAAP EPS: $3.43 (+63% YOY)
Adjusted EBITDA: $632M (+48% YOY)
Non-GAAP EPS: $4.23 (+53% YOY)
ir.halozyme.com/news/news-details/2025/HALOZYME-REPORTS-F… -
Halozyme, Inc.
@halozymeinc
🚨Investor Update🚨 During yesterday’s Investor Conference call, we ✅ reiterated 2024 financial outlook and 📈 raised 2025 & beyond guidance.
More details 👉 ir.halozyme.com/events/ -
Halozyme, Inc.
@halozymeinc
We’re closing out 2024 with some exciting news from our partners @argenxglobal, @Bristol_Myers and @TakedaPharma. Check out our latest news here: ir.halozyme.com/news/
-
Halozyme, Inc.
@halozymeinc
Members of the executive leadership team are scheduled to present and host investor meetings at the Piper Sandler 36th Annual Healthcare Conference and the 7th Annual Evercore ISI HealthCONx Conference. To learn more: ir.halozyme.com/news/news-details/2024/Halozyme-to-Presen…
-
Halozyme, Inc.
@halozymeinc
Last week, Halozyme reported financial and operating results for the third quarter and provided an update on our recent corporate activities and outlook. Press release here: ir.halozyme.com/news/news-details/2024/HALOZYME-REPORTS-T…
-
Halozyme, Inc.
@halozymeinc
Earlier today, we announced that we will share our third quarter 2024 financial and operating results on Thursday, October 31 following the close of trading.
ir.halozyme.com/news/news-details/2024/Halozyme-to-Report… -
Halozyme, Inc.
@halozymeinc
Attending PDA Universe of Pre-Filled Syringes & Injection Devices Conference this week? Don’t miss David Kang’s presentation on HVAI today at 10:55. Have questions? Stop by booth #925 to learn more.
#pdaups #subcutaneous #halozyme -
Halozyme, Inc.
@halozymeinc
Going to PDA Universe of Pre-Filled Syringes & Injection Devices Conference tomorrow? Don’t miss David Kang’s presentation on HVAI at 11:30. Have questions? Stop by booth #925 to learn more.
#pdaups #subcutaneous #hvai #halozyme -
Halozyme, Inc.
@halozymeinc
Join us at SMSNA tomorrow, Friday, October 18 at 7 am to learn how testosterone replacement may fit into your treatment approach. #halozyme #smsna24
-
Halozyme, Inc.
@halozymeinc
Going to PDA Universe of Pre-Filled Syringes & Injection Devices Conference? Don't miss David Kang's talks on high-volume auto-injectors on 10/22 at 11:20 and 10/23 at 10:55. #pdaups #subcutaneous #halozyme
-
Halozyme, Inc.
@halozymeinc
Join us at SMSNA next week on Friday, October 18 at 7 am to learn how testosterone replacement may fit into your treatment approach. #halozyme #smsna24
-
Halozyme, Inc.
@halozymeinc
Halozyme announces expansion of global collaboration and license agreement with argenx. Read more: ir.halozyme.com/news/news-details/2024/Halozyme-Announces…
#halozyme #subcutaneous #drugdelivery -
Halozyme, Inc.
@halozymeinc
ICYMI, the FDA approved two SC injections from #genenetch co-formulated with our drug delivery tech, providing patients and physicians with greater flexibility and expanded options for how treatments are administered. halozyme.com/news/
-
Halozyme, Inc.
@halozymeinc
Dr. Helen Torley and Tram Bui will present and meet investors at 2024 Wells Fargo Healthcare Conference, Morgan Stanley 22nd Annual Global Healthcare Conference, and H.C. Wainwright 26th Annual Global Investment Conference. To learn more: ir.halozyme.com/news/news-details/2024/Halozyme-to-Presen…
-
Halozyme, Inc.
@halozymeinc
Join our team and make an impact! 🚀 We're hiring for various roles and looking for passionate individuals. Check out our open positions and apply today: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs #nowhiring #careeropportunities #joinus #jobopening
-
Halozyme, Inc.
@halozymeinc
Halozyme released Q2 financial results, corporate updates, and future outlook. Check the highlights or dive into the full press release and earnings call here: ir.halozyme.com/events-and-presentations/events/event-det…
-
Halozyme, Inc.
@halozymeinc
Halozyme to Report Second Quarter 2024 Financial and Operating Results
Earlier today, we announced that we will share our second quarter 2024 financial and operating results on Tuesday, August 6, 2024, following the close of trading.
ir.halozyme.com/news/news-details/2024/Halozyme-to-Report… -
Halozyme, Inc.
@halozymeinc
At CRS Annual Meeting & Expo? We would love to see you at our presentation tomorrow at 8 am on “Clinical Trial to investigate the Tolerability of a Rapid 10 mL SC Injection of a Biologic Drug with Recombinant Human Hyaluronidase (rHuPH20) Using a HVAI in Healthy Subjects.”
-
Halozyme, Inc.
@halozymeinc
At CRS's Annual Meeting and Expo this week? Come check out our poster “Preclinical Evaluation of a HVAI for SC Injection of a Biologic Drug with Recombinant Human Hyaluronidase PH20 (rHuPH20)." Come swing by and say hello!
#halozyme #subcutaneous -
Halozyme, Inc.
@halozymeinc
Just a reminder: if you are attending CRS Annual Meeting and Expo this week, be sure to check out David Kang’s presentation tomorrow from 9:55-10:15 on “High Volume #subcutaneous Injection Device: Pushing the Injection Volume Boundaries.”
-
Halozyme, Inc.
@halozymeinc
Attending CRS Annual Meeting and Expo next week? Drop us a line to set up a meeting with David Kang, Marie Printz or Manual Sanchez-Felix and learn more about how Halozyme is reinventing the patient experience. 2024crsannualmeeting.eventscribe.net/index.asp #subcutaneous
-
Halozyme, Inc.
@halozymeinc
Happy Fourth of July from the Halozyme team! Have a wonderful and safe holiday!
#fourthofjuly #independanceday #freedom -
Halozyme, Inc.
@halozymeinc
#icymi, members of the Subcutaneous Drug Development & Delivery Consortium recently published a paper on “Optimizing Patient Experience and Treatment Adherence through SC Product Design.” www.sciencedirect.com/science/article/abs/pii/S0169409X24… #subcutaneous #halozyme
-
Halozyme, Inc.
@halozymeinc
Attending CRS Annual Meeting and Expo next week? Join us for a workshop on “Debunking the Myths of Subcutaneous Drug Delivery” on Monday, July 8 from 1:00 p.m. – 5:00 p.m. 2024crsannualmeeting.eventscribe.net
-
Halozyme, Inc.
@halozymeinc
Based on the new European patent for ENHANZE, Halozyme raised full year 2024 financial guidance and updated our 5-year financial outlook. Full press release here: ir.halozyme.com/news/news-details/2024/Halozyme-Raises-Fu… Additional details on the patent and 5-year financial outlook here: ir.halozyme.com/events-and-presentations/events/event-det…
-
Halozyme, Inc.
@halozymeinc
Yesterday, Halozyme announced a new European Patent covering the ENHANZE® rHuPH20 product. It will be validated in 37 European countries and expires on March 6, 2029. To access the press release, please visit ir.halozyme.com/news/news-details/2024/Halozyme-Announces…
-
Halozyme, Inc.
@halozymeinc
At #nbc2024 this week? Don’t forget to attend our presentation on “Recombinant Human Hyaluronidase Facilitated Subcutaneous Drug Delivery Using a 10mL HVAI" tomorrow from 11:15 AM – 12:00 PM in Learning Lab, Grand Ballroom AB. Hope to see you there!
-
Halozyme, Inc.
@halozymeinc
Earlier this week, we reported financial and operating results for the first quarter, and provided an update on recent corporate activities and outlook. We delivered another quarter of double-digit revenue and earnings growth. View the press release here: ir.halozyme.com/news/news-details/2024/HALOZYME-REPORTS-F…
-
Halozyme, Inc.
@halozymeinc
Will you be at #nbc2024 in SF next week? If so, be sure to attend our presentation on “Recombinant Human Hyaluronidase Facilitated Subcutaneous Drug Delivery Using a 10mL HVAI on 5/13 from 11:15 AM – 12:00 PM PT in Learning Lab, Grand Ballroom AB. Hope to see you there!
-
Halozyme, Inc.
@halozymeinc
Yesterday, Halozyme reported financial and operating results for Q4 2023 and FY ended Dec. 31 2023. Q4 revenue increased 27% YoY to $230M while FY 2023 revenue increased 26% YoY to $829M. Halozyme also announced a new $750M share repurchase program.
ir.halozyme.com/news/news-details/2024/HALOZYME-REPORTS-F… -
Halozyme, Inc.
@halozymeinc
Halozyme will host an Investor Business Forum and Long-Term Outlook Call on Wednesday, January 17, 2024 at 5:30 a.m. PT / 8:30 a.m. ET. During the call, we will discuss patent dynamics and provide 2024 financial guidance. Register here: event.on24.com/wcc/r/4466028/DE6CC4E2CB15DD3F698A862C08DC…
-
Halozyme, Inc. reposted
Roche
@Roche
#media: The CHMP has recommended the subcutaneous injection of our #cancer immunotherapy for approval in the EU for some of the most aggressive forms of cancer. Learn more: www.roche.com/media/releases/med-cor-2023-11-14
$RHHBY $ROG -
Halozyme, Inc.
@halozymeinc
We are excited to announce that Halozyme and @AcumenPharm have entered a global collaboration and non-exclusive license agreement for the ENHANZE® technology in Alzheimer’s disease. ir.halozyme.com/news/news-details/2023/Halozyme-and-Acume…
#halozyme #alzheimers -
Halozyme, Inc.
@halozymeinc
Halozyme recently reported our third quarter 2023 financial and operating results, including a 15% year-over-year increase in royalty revenue to a record $114.4 million.
We will continue to work toward achieving our 2023 financial and operational goals.
ir.halozyme.com/news/news-details/2023/HALOZYME-REPORTS-T… -
Halozyme, Inc.
@halozymeinc
Join us for a Sponsored Speaker Program at the SMSNA 24th Annual Fall Scientific Meeting in San Diego to learn about different auto-injection and oral delivery testosterone replacement therapy options.
#halozyme #smsna23 #trt #menshealth -
Halozyme, Inc.
@halozymeinc
#subcutaneous (SC) infusion is a promising way to deliver drugs, but it is limited by the inability of fluids to flow in the SC space. Luckily, researchers looked at how rHuPH20 can help overcome SC administration volume and time constraints.
pubmed.ncbi.nlm.nih.gov/37702020/
#halozyme -
Halozyme, Inc.
@halozymeinc
#halozyme aims to innovate in delivery technology for transformative therapies.
Our focus? To simplify treatments, reduce therapy time, and empower healthcare providers and patients with potentially life-changing drug delivery solutions.
halozyme.com -
Halozyme, Inc.
@halozymeinc
#halozyme is committed to improving #patientcare through our cutting-edge technology.
We aim to enhance and simplify medication administration while significantly reducing treatment time.
Learn how we're reinventing patient care: halozyme.com -
Halozyme, Inc.
@halozymeinc
Meet our VP of Development and Manufacturing, Dr. Anna-Maria Hays Putnam!
Anna-Maria is a strategic biopharmaceutical industry leader with experience ranging from pre-clinical through commercial, including life-cycle management for internal and partnered programs.
#halozyme -
Halozyme, Inc.
@halozymeinc
Cancer treatment, including IV #breastcancer therapy, can be time-consuming.
#halozyme is revolutionizing patient care with our #subcutaneous drug delivery technology that aims to reduce treatment time and improve patient care.
halozyme.com -
Halozyme, Inc.
@halozymeinc
We are excited to share this insightful episode of BioBreakthroughs by @SliceofHC featuring #halozyme’s President and CEO, Dr. Helen Torley. Learn more about our innovative drug delivery technology and our mission to reduce treatment burden.
Listen: www.sliceofhealthcare.com -
Halozyme, Inc.
@halozymeinc
Hear the results of our completed clinical study at #podd2023 today.
At 10:35 am EST, CTO Michael LaBarre will present the study results showcasing the benefits of our high volume auto-injector utilizing ENHANZE®.
Read our press release: ir.halozyme.com/news/news-details/2023/Update-Halozyme-An…
#halozyme -
Halozyme, Inc.
@halozymeinc
Halozyme’s Chief Technical Officer, Michael LaBarre, PhD, will be speaking at 5-5:15 pm EST about Halozyme’s ENHANZE® drug delivery technology and why it should be considered in combination with drug delivery devices, including auto-injectors.
#halozyme #subcutaneous -
Halozyme, Inc.
@halozymeinc
Attending #podd2023?
Don’t miss #halozyme’s CTO, Michael LaBarre, PhD, on Oct 16 & 17. Learn more about how our proprietary high volume auto-injector, together with ENHANZE, can enable rapid subcutaneous drug delivery.
Learn more: theconferenceforum.org/conferences/partners-in-drug-deliv… -
Halozyme, Inc.
@halozymeinc
Our CEO, Dr. Helen Torley, shared with @fox5sandiego how #halozyme is revolutionizing drug delivery.
Watch the interview to learn how we are elevating the patient experience by cutting treatment time and enhancing access.
www.youtube.com/watch?v=NAy3umhcqro
#subcutaneous -
Halozyme, Inc.
@halozymeinc
We're excited for the 2023 @PDAonline Universe of Pre-Filled Syringes and Injection Devices Conference in Gothenburg, Sweden!
On 10/17, Assoc. Director of Drug Delivery, David Kang, will present on #halozyme's innovations in subcutaneous drug delivery.
www.pda.org/global-event-calendar/event-detail/2023-pda-u… -
Halozyme, Inc.
@halozymeinc
Join us on Wednesday, October 25, 2023, for an interactive virtual speaker program to learn about #halozyme’s auto-injection and oral delivery testosterone replacement therapy options.
Reserve your spot! cvent.me/Pdx0PE -
Halozyme, Inc.
@halozymeinc
At #halozyme, patients are our priority.
With our innovative therapeutic options and disruptive drug delivery technology, we prioritize easing treatment burden and enhancing outcomes, always placing patients at the center of what we do.
#patientcare #innovation -
Halozyme, Inc.
@halozymeinc
At #halozyme, our employees shape our #companyculture by transforming patient care through collaboration & cutting-edge research, pushing boundaries in drug delivery.
Learn more from Dr. Helen Torley on the Life Science Success podcast with @5280dondavis: www.lifesciencesuccess.com/videos/episodes/dr-helen-torle… -
Halozyme, Inc.
@halozymeinc
A recent study found that patients with immune system disorders generally prefer #subcutaneous (SC) administration over IV infusion. Why? Convenience, comfort, and avoiding hospitals. @NCBI @NLM_NIH
pmc.ncbi.nlm.nih.gov/articles/PMC8064718/
#halozyme #patientcare -
Halozyme, Inc.
@halozymeinc
We're excited for @PDAonline's 2023 Universe of Pre-Filled Syringes and Injection Devices Conference in Gothenburg, Sweden!
On 10/17, our Director of Drug Delivery, David Kang, will present on #halozyme's innovations in subcutaneous #drugdelivery.
www.pda.org/global-event-calendar/event-detail/2023-pda-u… -
Halozyme, Inc.
@halozymeinc
#icymi: #halozyme's second-quarter financial and operational results for 2023 were highlighted last month.
These achievements fuel our pride as we focus on our 2023 financial and operational goals.
ir.halozyme.com/news/news-details/2023/HALOZYME-REPORTS-S… -
Halozyme, Inc.
@halozymeinc
The #halozyme team had a blast at our annual summer picnics last month! Delicious food, fantastic company, and loads of fun made for an unforgettable afternoon in each of our offices.
#companyculture -
Halozyme, Inc.
@halozymeinc
We look forward to attending @PDAonline's Universe of Pre-Filled Syringes and Injection Devices Conference in Gothenburg, Sweden. Don't miss a presentation by our Associate Director of Drug Delivery David Kang on 10/17!
www.pda.org/global-event-calendar/event-detail/2023-pda-u…
#halozyme #pdaprefilled -
Halozyme, Inc.
@halozymeinc
Hear more from our President and CEO, Helen Torley, about the work #halozyme is doing to improve the patient experience on the Life Science Success podcast with @5280dondavis.
www.youtube.com/live/7KQ0wvMwWdc?cbrd=1&ucbcb=1
#halozyme #subcutaneousdrugdelivery -
Halozyme, Inc.
@halozymeinc
We aim to revolutionize the patient experience with our ENHANZE® technology through subcutaneous drug delivery. By leveraging this unique technology, we hope to improve the quality of care and alleviate the burdens faced by patients.
halozyme.com/drug-delivery-technologies/enhanze/
#halozyme -
Halozyme, Inc.
@halozymeinc
During an interview with @BiotechTVHQ, Dr. Helen Torley, the President and CEO of Halozyme, discussed the potential of our ENHANZE® technology to improve the overall patient experience.
Watch the interview here: www.biotechtv.com/post/helen-torley-june-7-2023
#biotech #halozyme -
Halozyme, Inc.
@halozymeinc
ICYMI: In this @ClinicalLeader1 article, Halozyme's Chief Medical Officer, Dr. Stephen Knowles, discusses how to establish robust safety monitoring and reporting processes to navigate the regulatory landscape effectively.
www.clinicalleader.com/doc/you-re-a-small-biotech-how-sho…
#halozyme #patientsafety #icymi -
Halozyme, Inc.
@halozymeinc
Halozyme embraces diverse talents and perspectives. Our inclusive environment values and empowers employees, recognizing their contributions and supporting their career aspirations.
Learn more about our #dei initiatives here: halozyme.com/responsibility/
#halozyme -
Halozyme, Inc.
@halozymeinc
Watch our president & CEO, Helen Torley, live on @fox5sandiego today! She'll discuss how #halozyme is helping enhance patient experiences and treatment choices.
Watch the interview at 1 pm PT on Fox 5 News!
#halozyme -
Halozyme, Inc. reposted
Slice of Healthcare
@SliceofHC
Dr. Helen Torley, President & CEO at @halozymeinc $HALO shared her "thoughts" on putting the patient at the center of their treatment.
Check it out 👇
sliceofhealthcare.com/putting-the-patient-at-the-center-o…
#patientcentric #treatment
"It's not just about how well the treatment works, but how the patient feels during the process. What challenges do they face as they navigate the path to recovery?"
Dr. Torley was recently a guest on the BioBreakthroughs podcast. Stay tuned for its release! -
Halozyme, Inc.
@halozymeinc
#halozyme reported our second quarter 2023 financial and operating results, including a 45% revenue increase YOY to $221.0 million.
We are proud of our success thus far and will continue to work toward achieving our 2023 financial and operational goals.
ir.halozyme.com/news/news-details/2023/HALOZYME-REPORTS-S… -
Halozyme, Inc.
@halozymeinc
#icymi: @argenx received @US_FDA approval for VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) injection with ENHANZE® for subcutaneous (SC) use.
Read the full press release here: ir.halozyme.com/news/news-details/2023/Halozyme-Announces…
#fdaapproval #myastheniagravis -
Halozyme, Inc.
@halozymeinc
At #halozyme, we prioritize patient experience and ESG excellence, enhancing well-being and impacting society through ESG integration. Our dedication drives continuous enhancement, aligning goals with ESG values for a healthier, sustainable future.
halozyme.com/responsibility/ -
Halozyme, Inc.
@halozymeinc
In addition to treatment, we believe there are many other ways the #patientexperience can be improved, including the time between positive screenings and a formal diagnosis in #cancer patients.
Read this @Statnews article to learn more: www.statnews.com/2023/05/31/cancer-diagnosis-patient-navi… -
Halozyme, Inc.
@halozymeinc
At Halozyme, our focus revolves around the well-being of the patient. By leveraging our innovative drug delivery technologies and commercial portfolio, we are dedicated to revolutionizing the patient experience.
halozyme.com
#halozyme #patientexperience -
Halozyme, Inc.
@halozymeinc
Auto-injectors were created to simplify the process of administering medicines. Combined with our #drugdelivery expertise, we're excited about the future impact auto-injector technology can have on patients and healthcare providers. Learn more:
halozyme.com/drug-delivery-technologies/auto-injectors/ -
Halozyme, Inc.
@halozymeinc
. @Roche's Phase 3 OCARINA II trial for OCREVUS® (ocrelizumab) with ENHANZE® met primary and secondary endpoints.
The twice-yearly 10-minute subcutaneous injection showed positive results in adults with relapsing or primary progressive MS.
ir.halozyme.com/news/news-details/2023/Positive-Results-A… -
Halozyme, Inc.
@halozymeinc
Halozyme's Enhanze® technology can overcome the volume barriers of traditional #subcutaneous (SC) administration, facilitating rapid, large-volume SC injections and even larger SC infusions.
Watch the video on our website to learn more: halozyme.com/drug-delivery-technologies/enhanze/ -
Halozyme, Inc.
@halozymeinc
Why aren't more treatments given as subcutaneous injections instead of
intravenously? Part of the challenge is injecting large volumes under your skin.
Learn more about how we’re trying to solve that problem.
halozyme.com/drug-delivery-technologies/enhanze/
#subcutaneousdrugdelivery #halozyme -
Halozyme, Inc.
@halozymeinc
Halozyme is hiring! If you're looking to join a dynamic team that is passionate about what they do, and committed to positively impacting the lives of others, come join us!
View open positions here: halozyme.com/careers/
#werehiring #employmentopportunities #hiring -
Halozyme, Inc.
@halozymeinc
Our five core values drive our mission of improving #patientexperiences and outcomes.
They include:
- We respect and value the team
- We focus on patients
- We do the right thing
- We are all empowered and accountable
- We innovate
halozyme.com/about-us/
#halozyme -
Halozyme, Inc.
@halozymeinc
A research letter published in @JAMAOnc suggests U.S. medical facilities seem to underuse #subcutaneous drug delivery methods, specifically when it comes to cancer medications.
Read more about the study here: www.healio.com/news/hematology-oncology/20230512/despite-…
#subcutaneousdrugdelivery #oncology -
Halozyme, Inc.
@halozymeinc
Globally validated and currently used in five approved therapeutics with several other products in development, ENHANZE® technology is paving the way for #subcutaneousdrugdelivery.
View our partner pipeline here: halozyme.com/drug-delivery-technologies/enhanze/ -
Halozyme, Inc.
@halozymeinc
At Halozyme, we are committed to doing the right thing in the right way. Our #corporateresponsibility focuses on our employees, environment, governance and ethics, and community.
Learn more here: halozyme.com/responsibility/
#halozyme #subcutaneousdrugdelivery -
Halozyme, Inc.
@halozymeinc
Last week our team hosted our inaugural Dedicated Service Time, a day dedicated to giving back. Over 170 individuals showed up across three volunteer sites to support 14 organizations. Thank you to all attendees who made this event possible!
#halozyme #halohelps -
Halozyme, Inc.
@halozymeinc
Halozyme is delighted to share that @argenxglobal has received @US_FDA approval for VYVGART® Hytrulo injection with ENHANZE® for subcutaneous use. (1/2)
Halozyme, Inc.
@halozymeinc
The therapeutic treats adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive.
Learn more here: ir.halozyme.com/news/news-details/2023/Halozyme-Announces…
#fdaapproval #myastheniagravis (2/2) -
Halozyme, Inc.
@halozymeinc
Our President and CEO, Helen Torley and Paul Bono (@WaveLifeSci), will speak at a @GSK-sponsored @IAmBiotech session, discussing how companies, like #halozyme and @ViiVHC, are collaborating to develop therapies.
www.bio.org/events/bio-international-convention/sessions/…
#bio2023 #wewontstop #viivhealthcare -
Halozyme, Inc.
@halozymeinc
Halozyme's technologies are changing the game in healthcare.
With the potential to streamline treatment protocols, we're committed to reinventing the patient experience with our #therapies and giving #healthcareproviders new treatment solutions.
halozyme.com/about-us/ -
Halozyme, Inc.
@halozymeinc
Cancer patients spend hours at hospitals or clinics receiving IV treatments. Our ENHANZE® technology was made to help reduce this time, allow drugs to be delivered subcutaneously, and help improve the patient experience.
halozyme.com/drug-delivery-technologies/enhanze/
#drugdelivery -
Halozyme, Inc.
@halozymeinc
Meet Dr. Helen Torley, President and CEO of Halozyme! Dr. Torley has extensive expertise and leadership experience within the #biotech industry.
Read Dr. Torley's full bio here: halozyme.com/leadership/helen-torley-m-b-ch-b-m-r-c-p/
#drugdelivery #leadership -
Halozyme, Inc.
@halozymeinc
Used to facilitate the #subcutaneous delivery of injected drugs and fluids, our commercially validated ENHANZE® #drugdelivery technology can potentially reduce treatment from hours of IV infusions to subcutaneous injections that take only minutes.
halozyme.com/about-us/ -
Halozyme, Inc.
@halozymeinc
#teambuilding can be sweet!
Last week teams from across the company joined in some team-building activities, including a marshmallow tower contest.
Only one tower could win, but everyone gained some great insights into working together and had fun in the process!
#oneteam -
Halozyme, Inc.
@halozymeinc
#halozyme recently reported our first quarter 2023 financial and operating results, including a 38% revenue increase YOY to $162.1 million.
We look forward to continuing the success we have seen thus far in achieving our 2023 goals.
Read more: ir.halozyme.com/news/news-details/2023/HALOZYME-REPORTS-F… -
Halozyme, Inc.
@halozymeinc
#dyk: We're changing the #drugdelivery landscape by helping to make subcutaneous administration of IV products simpler and faster, potentially lessening the treatment burden for patients and providers.
Learn more about how we're doing it: halozyme.com/drug-delivery-technologies/
#enhanze -
Halozyme, Inc.
@halozymeinc
The burden of treatment for cancer isn't purely physical. It's estimated 1 in 3 cancer patients experience mental or emotional distress, and we hope our mission to make drug delivery easier and faster will help ease the mental burden of treatment.
#mentalhealthmonth #halozyme -
Halozyme, Inc.
@halozymeinc
Join us for a Sponsored Speaker Program at the @SMSNA_ORG 28th Annual Scientific Program at #aua2023 to learn about auto-injection and oral delivery testosterone replacement therapy options.
www.smsna.org/smsaua2023/sponsors/industry-sponsored-lunc… -
Halozyme, Inc.
@halozymeinc
Giving back is an important part of our mission. In celebration of this year's #earthday, the Halozyme team cleaned up the beautiful Los Peñasquitos Trail in San Diego. When we work together, big things happen.
#halohelps -
Halozyme, Inc.
@halozymeinc
Just a reminder to join us later today for a Sponsored Speaker Program to learn about Halozyme’s auto-injection and oral delivery testosterone replacement therapy options. web.cvent.com/event/ba7aa5e0-279d-4d80-a5b5-731777838740/…
-
Halozyme, Inc.
@halozymeinc
Join us for a Sponsored Speaker Program to learn about Halozyme’s auto-injection and oral delivery testosterone replacement therapy options. Register today! web.cvent.com/event/ba7aa5e0-279d-4d80-a5b5-731777838740/…
-
Halozyme, Inc.
@halozymeinc
Thank you to @barronsonline for recognizing us as one of the 100 most sustainable companies in the U.S. in 2023. Our social responsibility is to operate sustainably to deliver benefits for all our stakeholders & the environment. Check out our ESG efforts: halozyme.com/responsibility/
-
Halozyme, Inc.
@halozymeinc
Help us recognize #rarediseaseday by joining @RareDiseases to raise our voices and show support for the ~25 million Americans living with a #raredisease. #showyourstripes and learn more about rare diseases here: rarediseases.org @rarediseaseday
-
Halozyme, Inc.
@halozymeinc
We’re expanding our team and seeking to fill our Senior Director, Alliance Management role to further establish Halozyme as a preferred strategic partner of choice. Learn more about the open position and working with our Halozyme: halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs… #oneteam
-
Halozyme, Inc.
@halozymeinc
Last week, we announced our Q4 2022 and year end results. Learn more about our recent progress and upcoming milestones for the year ahead: events.q4inc.com/event/report/379653540?pwd=%24snQ57Ma
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we prioritize building strong and long-lasting relationships with our community. Dive into our ESG report to learn more about our community efforts and progression in the past year. halozyme.com/wp-content/uploads/Halozyme_ESG-Brochure-202…
-
Halozyme, Inc.
@halozymeinc
We moved! Our San Diego team is beyond excited to be able to make new memories in a new space and is incredibly proud of our growth that supports this latest adventure!
-
Halozyme, Inc.
@halozymeinc
#icymi, Feb. 4 was #worldcancerday. At Halozyme, our primary focus is the health of our patients, including those living with #cancer. We are proud to join the initiative to #closethecaregap and increase awareness of the disparity of cancer care access. www.worldcancerday.org
-
Halozyme, Inc.
@halozymeinc
Our Executive Director of Medical and Drug Safety, Susan Kindig, will participate at this year’s @DrugInfoAssn Global Pharmacovigilance and Risk Management Strategies Conference tomorrow at 8 am ET. #gpvrms23
-
Halozyme, Inc.
@halozymeinc
Halozyme is hiring! We are expanding our Finance team and seeking a Senior Accountant, Tax. Learn more about the open position here if you are looking to collaborate as #oneteam to deliver meaningful innovations to impact people’s lives: halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/job/…
-
Halozyme, Inc.
@halozymeinc
Today we honor Dr. Martin Luther King Jr., whose persistent dedication to equality continues to be an example to all of us today. We thank #mlk & all those in constant pursuit of creating a more equitable world.
-
Halozyme, Inc.
@halozymeinc
This week, our President & CEO, Helen Torley, presented at the 41st Annual @jpmorgan Healthcare Conference on our 2023 outlook. We always enjoy attending JPM & look forward to next year’s conference! #jpm23 #jpmhc23
-
Halozyme, Inc.
@halozymeinc
Save the date! Tomorrow, our President & CEO, Helen Torley, will be presenting at the 41st Annual J.P. Morgan Healthcare Conference at 3:45 pm PT #jpm23 #jpmhc23 ir.halozyme.com/news/news-details/2023/Halozyme-to-Presen…
-
Halozyme, Inc.
@halozymeinc
#happynewyear from Halozyme. We're grateful to our team & community for our accomplishments this year — from advancing our ENHANZE platform, adding autoinjector tech with our successful Antares acquisition & building our #oneteam. We look forward to what we’ll accomplish in 2023!
-
Halozyme, Inc.
@halozymeinc
The Halozyme team wishes everyone a happy and healthy holiday season. As we wrap up 2022, we hope you take this time to reflect and enjoy moments spent with those who mean the most. #happyholidays
-
Halozyme, Inc.
@halozymeinc
This month, we are proud to spotlight our team member, Nancy Salvatici, Office Manager & Executive Assistant, who recently joined Halozyme! Learn more about why she enjoys working here and Halozyme’s #oneteam culture.
-
Halozyme, Inc.
@halozymeinc
Halozyme is #hiring! Our team is looking for a highly qualified individual to fill our Process Engineer 2 position. Check out some of the responsibilities below and learn more about the role here: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs
-
Halozyme, Inc.
@halozymeinc
Today, our Senior Vice President & CFO, Nicole LaBrosse is presenting at the 5th Annual Evercore ISI HealthConx Conference. Tune into the presentation to hear about our technology, commercial portfolio, and pipeline opportunities. ir.halozyme.com/events-and-presentations/events/event-det…
-
Halozyme, Inc.
@halozymeinc
Today, our President & CEO, Helen Torley is participating in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference. Tune into the broadcast to learn more about our innovative drug delivery technologies. event.webcasts.com/starthere.jsp?ei=1583068&tp_key=24c365…
-
Halozyme, Inc.
@halozymeinc
Halozyme is #hiring! Our team is searching for an experienced #biopharma leader to fill our Senior Director, Alliance Management position. If you are looking for a driven team, check out the role. halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs…
-
Halozyme, Inc.
@halozymeinc
Today, we announced our third quarter 2022 financial and operating results. Read more about the Company’s accomplishments in the press release. ir.halozyme.com/news/news-details/2022/HALOZYME-REPORTS-T…
-
Halozyme, Inc.
@halozymeinc
Join us for a live sponsored Product Theater* at the 23rd Annual Fall Scientific Meeting of @SMSNA_ORG & 23rd ISSM Scientific on Friday, October 28, 2022 at 12 pm ET.
-
Halozyme, Inc.
@halozymeinc
Our team will be presenting at the #podd2022 conference in Boston. Be sure to check out our talks to learn about our ENHANZE® drug delivery technology and more.
-
Halozyme, Inc.
@halozymeinc
Today, we are spotlighting Elizabeth Valentine, Director, Product Development, Strategic Liaison. Thank you for your passion and commitment to our mission of having a positive impact on the lives of patients and their families around the world.
-
Halozyme, Inc.
@halozymeinc
October is #globaldiversityawarenessmonth. Halozyme is proud to be a #diverse & #inclusive workplace and to have adopted @IAmBiotech’s DEI principles on workforce development. halozyme.com/responsibility
-
Halozyme, Inc.
@halozymeinc
We are looking forward to attending the 2022 @AAPSComms PHARMSCI 360 Conference in Boston. Visit us at Booth 1327 for the opportunity to learn more about our ENHANZE drug delivery technology and autoinjector platforms.
-
Halozyme, Inc.
@halozymeinc
Halozyme is #hiring! We are looking for a Commercial Counsel to help expand our legal team within the Medical, Legal and Regulatory Affairs Committee. Learn more about our open position here: halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs…
-
Halozyme, Inc.
@halozymeinc
October is #breastcancerawarenessmonth. At Halozyme, our primary focus is improving treatment options for patients, including those living with #breastcancer. This year we join @NBCF and their #rise initiative - Rally in Screening Everyone. www.nationalbreastcancer.org/about-breast-cancer/
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we strive to build a diverse team of committed people who bring unique talents and perspectives to the table. This month we are highlighting Carlos Rey, Associate Director, Supply Chain on his experience at Halozyme. #oneteam
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we are building a diverse team who is enthusiastic and dedicated to making a positive impact on the lives of not only our patients but their families too. Learn more about our efforts on #diversity & #inclusion. halozyme.com/responsibility/
-
Halozyme, Inc.
@halozymeinc
Today is #worldpatientsafetyday, which brings together patients, families, caregivers & healthcare communities to increase awareness of patient safety. At Halozyme, we are committed to this year’s theme – Medication Safety – through our core value “We Focus on Patients.”
-
Halozyme, Inc.
@halozymeinc
Today is the start of National #hispanicheritagemonth! We recognize the contributions & important presence that Hispanic Americans have had on our country’s history & achievements. We honor this month as we continue to build a diverse & inclusive team.
-
Halozyme, Inc.
@halozymeinc
We’re #hiring! Halozyme is expanding our Manufacturing team. We are looking for a Senior Manager, Manufacturing – Drug Substance to join our team and contribute to our mission of providing innovative & disruptive drug delivery solutions.
halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs… -
Halozyme, Inc.
@halozymeinc
Tomorrow, our President & CEO, Helen Torley, will present at the 2022 @WellsFargo Healthcare Conference. Tune in on Thursday, September 8th at 8:35 a.m. ET. cc.webcasts.com/well001/090722a_js/?entity=43_BH7XQTO
-
Halozyme, Inc.
@halozymeinc
Happy #womensequalityday! Today, we are highlighting Sara Coon, our Director of Regulatory Affairs, Devices. Sara shares her thoughts as she reflects on the impact women mentors and colleagues have had on her career. #oneteam
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we are committed to maintaining a #diverse & #inclusive work community and culture. Our team has adopted the @IAmBiotech’s principles on workforce development, diversity and inclusion. Learn more. halozyme.com/responsibility/
-
Halozyme, Inc.
@halozymeinc
Halozyme is #hiring! Our team is seeking a Senior Process Engineer 1 to join our rapidly expanding Halozyme community. Find out more about this position here: halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs…
-
Halozyme, Inc.
@halozymeinc
This month is #nationalwellnessmonth. Our team recently enjoyed a weeklong summer reset which allowed time for everyone to step back from work and focus on self-care as well as time with family and friends. See highlights from our “Inspire Week” 2022. #oneteam
-
Halozyme, Inc.
@halozymeinc
Today, we announced our second quarter 2022 financial and operating results. Learn more about our accomplishments and updated expectations here: halozyme.com/news/ $HALO
-
Halozyme, Inc.
@halozymeinc
Our core values unite us at Halozyme. As we relentlessly work toward our mission of improving patient experiences and outcomes, these values represent the core of each and every one of our team members. Read more about #ourvalues.
halozyme.com/about-us/ #oneteam -
Halozyme, Inc.
@halozymeinc
Stay up-to-date on all recent and upcoming Halozyme activity by registering for IR email alerts. Never miss out on company updates, news, SEC filings, etc. You can sign up for alerts in our website here. ir.halozyme.com/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
We’re hiring! Halozyme is looking for a top-tier candidate to fill our Director of Corporate Communications & Investor Relations position and join a collaborative team with a shared mission to expand treatment options for patients in need. #hiring halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs…
-
Halozyme, Inc.
@halozymeinc
Happy 4th of #july from our team at Halozyme! We are wishing everyone a festive and restful holiday weekend with friends, family and loved ones. #independenceday
-
Halozyme, Inc.
@halozymeinc
We are spotlighting a new member of our Halozyme #oneteam, Heather Reppert. Heather joins from our recent acquisition & serves as a Contracts Paralegal. Welcome to the team, Heather, & thank you for your dedication in helping us improve the experiences of our partners & patients!
-
Halozyme, Inc.
@halozymeinc
We are working to improve the patient experience through our proprietary ENHANZE® drug delivery technology. ENHANZE® helps to inspire new possibilities by helping to rapidly deliver subcutaneous therapies for patients in need. halozyme.com/enhanze/
-
Halozyme, Inc.
@halozymeinc
We are #hiring an Accounting Manager, Accounts Payable to join a team culture that welcomes diversity, thinks differently to solve problems, works collaboratively as one team, and delivers meaningful innovations that impact people’s lives. halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs…
-
Halozyme, Inc.
@halozymeinc
Today, our President & CEO, Helen Torley will be participating in a fireside chat at the @GoldmanSachs Healthcare Conference. Tune in at 11:00am EST / 8:00am PST. kvgo.com/gs/halozyme-therapeutics-inc-june-2022 $HALO
-
Halozyme, Inc.
@halozymeinc
Today is #nationalcancersurvivorsday. We are recognizing cancer survivors, raising awareness of the ongoing challenges cancer survivors face, and – most importantly – celebrating life. Learn more from @SurvivorsDay ncsd.org/about-us/
-
Halozyme, Inc.
@halozymeinc
We are #hiring! The Sr. Process Engineer 1, will be a key contributor in one or more fields of protein process technology transfer, process validation, and large-scale drug substance manufacturing helping significantly improve patient experiences. halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs…
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting Getasew Yesegat, Associate Director, Financial Reporting & Technical Accounting. He works towards Halozyme's mission to bring innovative and disruptive solutions with a goal of significantly improving patient experiences. #oneteam
-
Halozyme, Inc.
@halozymeinc
Halozyme Completes Antares Pharma Acquisition www.prnewswire.com/news-releases/halozyme-completes-antar…
-
Halozyme, Inc.
@halozymeinc
In honor of Asian American, Native Hawaiian & Pacific Islanders Heritage Month, our team is spotlighting the achievements of prominent #aanhpi scientists. Check out a few of our featured scientists. #aanhpimonth
-
Halozyme, Inc.
@halozymeinc
Halozyme today reports financial results for the first quarter ended March 31, 2022 and provides an update on its recent corporate activities and outlook. ir.halozyme.com/overview/default.aspx www.prnewswire.com/news-releases/halozyme-reports-first-q…
-
Halozyme, Inc.
@halozymeinc
-
Halozyme, Inc.
@halozymeinc
Halozyme To Host First Quarter 2022 Financial Results Webcast and Conference Call on May 10 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen Torley, president, and chief executive officer will lead the call. www.prnewswire.com/news-releases/halozyme-to-host-first-q…
-
Halozyme, Inc.
@halozymeinc
Halozyme Commences Tender Offer For All Outstanding Shares of Common Stock Of Antares Pharma www.prnewswire.com/news-releases/halozyme-commences-tende…
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting our Senior Director, Project Management, Alice Lee, M.S. Alice is one of the many women who are working toward Halozyme's mission to bring innovative and disruptive solutions with a goal of significantly improving patient experiences. #oneteam
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we strive to be stewards of protecting our environment and care deeply about our world & natural resources. Our mindset is “think globally, act locally” when it comes to promoting environmental sustainability within our own operations. #earthday2022
-
Halozyme, Inc.
@halozymeinc
We are #hiring for a Associate Director Drug Product Manufacturing position! This individual is a key leader and contributor within the CMC organization. Learn more about the position here: halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/jobs…
-
Halozyme, Inc.
@halozymeinc
Halozyme and Antares Pharma announced they have entered into a definitive agreement pursuant to which Halozyme will acquire Antares. The combination will create a leading specialty product and drug delivery company. www.prnewswire.com/news-releases/halozyme-to-acquire-anta…
-
Halozyme, Inc.
@halozymeinc
#nationalminorityhealthmonth raises awareness about the health disparities that continue to affect minority communities. At Halozyme, we are dedicated to improving health equity & patient experiences through our ENHANZE technology. Learn more about #nmhm. www.nimhd.nih.gov/programs/edu-training/nmhm/
-
Halozyme, Inc.
@halozymeinc
This month, our team launched #modernhealth – a platform focused on investing in our employee's wellness. Modern Health allows us to provide mental health services to employees & further enhance our work culture & community. www.modernhealth.com #worldhealthday2022 #oneteam
-
Halozyme, Inc.
@halozymeinc
After 2 years apart, our Halozyme team is officially back together this week! Our new hybrid model has us in the office two days a week. We are excited to welcome all employees back to our main offices in San Diego, CA. #welcomeback #oneteam
-
Halozyme, Inc.
@halozymeinc
We are committed to employee development as an essential driver of our future growth & success. In 2021, we launched the Inspired Journey program designed to empower employees to create a personalized learning & development path. Learn more. halozyme.com/wp-content/uploads/Halozyme_ESG-Brochure-202…
-
Halozyme, Inc.
@halozymeinc
Halozyme is #hiring! We are seeking a Senior Scientist, Upstream Process Development to help expand our Process Development team within the Manufacturing Science and Technology department. Learn about our open position here: halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/job/…
-
Halozyme, Inc.
@halozymeinc
Halozyme Therapeutics, Inc. and Chugai Pharmaceutical Enter Global Collaboration and License Agreement for ENHANZE® Technology www.prnewswire.com/news-releases/halozyme-therapeutics-in…
-
Halozyme, Inc.
@halozymeinc
We are appreciative for the support of our partners who relentlessly work by our side to help improve patient experiences & outcomes. Interested in potential partnership opportunities? Reach out to our business development team at bd@halozyme.com or visit halozyme.com/enhanze/
-
Halozyme, Inc.
@halozymeinc
At Halozyme, our goal is to improve patient experiences and outcomes for emerging & established therapies. With our proprietary ENHANZE® drug delivery technology, we're looking to break through traditional limitations and deliver high volume SC therapies for patients in need.
-
Halozyme, Inc.
@halozymeinc
Positive Topline Results Announced from ADAPT-SC Study Evaluating Subcutaneous Efgartigimod Using ENHANZE® Drug Delivery Technology for Generalized Myasthenia Gravis www.prnewswire.com/news-releases/positive-topline-results…
-
Halozyme, Inc.
@halozymeinc
Today, we are spotlighting our Senior Regulatory Affairs Specialist 1, Helen Lee. We thank you for your commitment to supporting our regulatory department and representing our core value to "Respect and Value The Team" while significantly improving patient experiences. #oneteam
-
Halozyme, Inc.
@halozymeinc
Halozyme Appoints Moni Miyashita to its Board of Directors. Ms. Miyashita is an accomplished executive with over 25 years of global strategic, mergers & acquisitions and business transformation expertise. www.prnewswire.com/news-releases/halozyme-appoints-moni-m…
-
Halozyme, Inc.
@halozymeinc
We celebrate #ethnicequalitymonth & #genderequalitymonth by recognizing how a diverse workplace brings new talents, backgrounds & perspectives to the work we do every day. At Halozyme, we value diversity in all aspects of our business, leading to greater growth & success!
-
Halozyme, Inc.
@halozymeinc
Today is #internationalwomensday! At Halozyme, we make having a diverse workforce with strong female leaders and employees a top priority. Learn about this year’s #iwd campaign from @womensday and how to get involved here: www.internationalwomensday.com/Theme
-
Halozyme, Inc.
@halozymeinc
In honor of #rarediseaseday, Halozyme joins NORD (@RareDiseases) in showing support, offering resources, and helping raise awareness for the over 25 million Americans affected by rare diseases. Learn how you can #showyourstripes and join the movement. rarediseases.org/rare-disease-day/
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting our recently appointed Senior VP & CFO, Nicole LaBrosse. Nicole possesses the financial & business skill set to support Halozyme's growth. Thank you for your dedication in helping us improve the experiences of our partners & patients. #oneteam
-
Halozyme, Inc.
@halozymeinc
Yesterday, we announced our fourth quarter 2021 and full year results. Learn more about our recent progress and upcoming milestones here: ir.halozyme.com/news/news-details/2022/HALOZYME-REPORTS-F… $HALO
-
Halozyme, Inc.
@halozymeinc
Halozyme Reports Fourth Quarter 2021 and Full Year Results
halozyme.com/news/ www.prnewswire.com/news-releases/halozyme-reports-fourth-… -
Halozyme, Inc.
@halozymeinc
Today at 1:30 p.m. PT/4:30 p.m. ET Halozyme will reports its Fourth Quarter 2021 and Full Year results. Dr. Helen Torley, president and chief executive officer will lead the call. ir.halozyme.com/events-and-presentations/default.aspx
-
Halozyme, Inc.
@halozymeinc
We’re hiring! Halozyme is looking to expand our Analytical team within the Manufacturing Science and Technology group. We are seeking a Sr. Scientist 1. Learn more about the open position here: halozyme.com/careers/
-
Halozyme, Inc.
@halozymeinc
We are inspiring new partnerships by collaborating with leading pharmaceutical and biopharma companies. Thank you, partners, for your support in helping us develop solutions to improve patient experiences. Learn more about our partnerships here: halozyme.com/enhanze/
-
Halozyme, Inc.
@halozymeinc
Happy Valentine’s Day from our team to yours! Employees are the heart of Halozyme and critical to the sustainability of our business. We love what we do because our employees bring to life every aspect of our values and culture. #valentinesday
-
Halozyme, Inc.
@halozymeinc
Halozyme will webcast its Quarterly Update Conference Call for the 4th qtr. 2021 on Feb. 22 at 4:30 p.m. ET. Dr. Helen Torley, president and chief executive officer will lead the call. ir.halozyme.com/overview/default.aspx www.prnewswire.com/news-releases/halozyme-to-host-fourth-…
-
Halozyme, Inc.
@halozymeinc
ICYMI: At Halozyme, we are committed to making a difference in our community by building positive and sustainable relationships with local organizations. View our ESG report to learn more about the community organizations that we support. halozyme.com/wp-content/uploads/Halozyme_Brochure-2021_Fi…
-
Halozyme, Inc.
@halozymeinc
In honor of #blackhistorymonth – our team commemorates the achievements made by Black Americans throughout U.S. history. At Halozyme, we celebrate the unique talents, backgrounds & perspectives each employee brings to the workplace. Learn more about #bhm: www.history.com/articles/black-history-month
-
Halozyme, Inc.
@halozymeinc
Halozyme Appoints New Chief Financial Officer www.prnewswire.com/news-releases/halozyme-appoints-new-ch…
-
Halozyme, Inc.
@halozymeinc
Honored to be included on @Forbes’ annual list of America’s Best Mid-Sized Companies - the only Drug & Biotech company! Rankings based on earnings & sales growth, return on equity, and total stock return for the prior 12 months and over last five years.
www.forbes.com/lists/best-mid-cap-companies/ -
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting our new Sr. VP, General Counsel, Chief Compliance Officer and Corporate Secretary, Mark Snyder. Excited to have you on Halozyme's executive leadership team. #oneteam ir.halozyme.com/news/news-details/2021/HALOZYME-APPOINTS-…
-
Halozyme, Inc.
@halozymeinc
Halozyme is hiring! Join a team of diverse individuals who are passionate about revolutionizing drug delivery technology. We are seeking a driven member to fill our Director, Quality Assurance position. View all open positions here: halozyme.com/careers/
-
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
Today we honor the life and legacy of Dr. Martin Luther King Jr. whose mission of championing equality and eliminating discrimination serve as a continued example of justice every day. #mlkday
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we strive to build a sustainable, environmentally conscious business while fulfilling our mission of bringing disruptive solutions that can significantly improve patient experiences & outcomes. Learn more in our recent 2021 ESG Report: halozyme.com/responsibility/
-
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
Today starts the 40th Annual @jpmorgan Health Care Conference. Halozyme’s President & CEO, Helen Torley, is presenting today at 7:30a.m. PT/10:30a.m. ET #jpmhc22. ir.halozyme.com/events-and-presentations/default.aspx
-
Halozyme, Inc.
@halozymeinc
Halozyme Provides 2022 Financial Guidance and Outlook www.prnewswire.com/news-releases/halozyme-provides-2022-f…
-
Halozyme, Inc.
@halozymeinc
As we begin #2022, our team at Halozyme would like to thank all our partners, patients, shareholders and employee community. We look forward to continuing our goal of significantly improving patient experiences, and potentially outcomes, for emerging and established therapies.
-
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
Halozyme's President & CEO, Helen Torley, will be presenting at the 40th Annual @jpmorgan Healthcare Conference on Jan. 10 @ 10:30 a.m. ET. #jpmhc22 ir.halozyme.com/events-and-presentations/events/default.aspx
-
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
Our Halozyme team is reflecting on the past year and all the progress we have made toward our mission of bringing innovative & disruptive solutions which seek to improve the patient experience. We wish you a happy & healthy New Year. Cheers to 2022! #newyearseve
-
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
Our Halozyme community wishes you and yours a very happy holiday season surrounded by friends, family and loved ones. #happyholidays
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting Robert Markovich, Senior Director of Analytical Development from our Halozyme community. He shares why he joined Halozyme. #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
We are honored to be hosting a holiday donation drive with the Boys & Girls Clubs of Greater San Diego (@BGCGSD) to support families who are in need to learn more. www.sdyouth.org
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we are improving the patient experience through our proprietary ENHANZE® drug delivery technology. ENHANZE® helps to inspire new possibilities by breaking through traditional limitations and deliver rapid subcutaneous therapies for patients in need.
-
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
Halozyme Appoints New General Counsel www.prnewswire.com/news-releases/halozyme-appoints-new-ge…
-
Halozyme, Inc.
@halozymeinc
Halozyme is hiring! Our team is looking for a high-quality individual to fill our Senior Director, Alliance Management position. Learn more about our open positions here: halozyme.com/careers/
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES $750 MILLION THREE-YEAR SHARE REPURCHASE PROGRAM www.prnewswire.com/news-releases/halozyme-announces-750-m…
-
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
NOW ON-DEMAND. Dr. Stephen Knowles, Chief Medical Officer at #halozyme, discusses the opportunities and challenges in large volume (>2 mL) SC drug delivery. www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
Today, our President & CEO, Helen Torley will be participating in a virtual fireside chat at the 4th Annual @EvercoreISI HealthCONx Conference. Tune in at 3:55 p.m. EST / 12:55 p.m. PST.
ir.halozyme.com/events-and-presentations/events/event-det… -
Halozyme, Inc.
@halozymeinc
Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® in combination with Carfilzomib and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
In honor of #worldaidsday, we join our partners at @ViiVHC in helping raise awareness and showing support for people living with #hiv. Together, our teams are collaborating to create new delivery options for innovative medicines to treat and prevent HIV.
-
Halozyme, Inc.
@halozymeinc
At Halozyme, our goal is to improve patient experiences and outcomes for emerging & established therapies. With our proprietary ENHANZE® drug delivery technology, we're looking to break through traditional limitations and deliver high volume SC therapies for patients in need.
-
Halozyme, Inc.
@halozymeinc
Happy Thanksgiving Day! We are thankful for our dedicated employees, partners, and community. We hope you all have a wonderful holiday with your family, friends and loved ones. #thanksgiving
-
Halozyme, Inc.
@halozymeinc
Our SVP & CFO, Elaine Sun, presented at the @Piper_Sandler Virtual Healthcare Conference. The corporate presentation is available on-demand starting today. Click here to access the content: ir.halozyme.com/events-and-presentations/events/event-det… $HALO
-
Halozyme, Inc.
@halozymeinc
Did you know that 1 in 2 women and 1 in 3 men will develop cancer within their lifetime? Through our strategic collaborations, we are proud to be developing additional treatment options for individuals with cancer.
-
Halozyme, Inc.
@halozymeinc
Our team participated in a Halloween #pumpkin carving contest. Take a look at all the fun and spooky pumpkins from our talented team! #halloween
-
Halozyme, Inc.
@halozymeinc
Halozyme to Present at Two Upcoming Investor Conferences - 33rd Annual Piper Sandler Virtual Healthcare Conference and Evercore ISI 4th Annual HealthCONx Conference. www.prnewswire.com/news-releases/halozyme-to-present-at-u…
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting Tatiana Burhani. Thank you for your continued commitment to our mission of bringing innovative and disruptive solutions to partners with a goal of significantly improving patient experiences. #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
We’re hiring! Halozyme is looking to expand our team in the Process Development and Manufacturing department. We are seeking a Process Development Scientist 2. Learn more about our open positions here: halozyme.com/careers/
-
Halozyme, Inc.
@halozymeinc
Happy Veterans Day! We are thankful for all the Veterans who make up our Halozyme team! Thank you for your service. #veteransday
-
Halozyme, Inc.
@halozymeinc
Subcutaneous administration of large volume injections has the potential to be more patient-centric, convenient and efficient. Join our #echalktalk discussion with Dr. Stephen Knowles to learn more: #halozyme #enhanzedrugdeliverytechnology @AAPSComms www.pathlms.com/aaps/account/inactive
-
Halozyme, Inc.
@halozymeinc
Subcutaneous administration of large volume injections has the potential to be more patient-centric, convenient and efficient. Join our #echalktalk discussion with Dr. Stephen Knowles to learn more: #halozyme #enhanzedrugdeliverytechnology @AAPSComms www.pathlms.com/aaps/account/inactive
-
Halozyme, Inc.
@halozymeinc
Don’t miss it! REGISTER NOW for our #echalktalk Live Webinar & Discussion Nov 10th on the possibilities of large volume SC drug delivery with Dr. Stephen Knowles, Chief Medical Officer at #halozyme #enhanzedrugdeliverytechnology @AAPSComms
www.pathlms.com/aaps/account/inactive -
Halozyme, Inc.
@halozymeinc
REGISTER NOW for our upcoming #echalktalk Live Webinar & Discussion Nov 10th on the possibilities of large volume SC drug delivery with Dr. Stephen Knowles, Chief Medical Officer at #halozyme #enhanzedrugdeliverytechnology @AAPSComms [Register]
-
Halozyme, Inc.
@halozymeinc
REGISTER NOW to get your questions about large volume (>2 mL) SC drug delivery answered. Join Dr. Stephen Knowles as he discusses how rapid, large volume SC administration is possible. #halozyme #enhanzedrugdeliverytechnology #echalktalk @AAPSComms
www.pathlms.com/aaps/account/inactive -
Halozyme, Inc.
@halozymeinc
Only 2 days left — #echalktalk on November 10th at 1:15pm EST! Join us for a quick learning session on large volume SC drug delivery, followed by an interactive conversation with #halozyme Chief Medical Officer, Dr. Stephen Knowles. @AAPSComms
www.pathlms.com/aaps/account/inactive -
Halozyme, Inc.
@halozymeinc
Subcutaneous administration of large volume injections has the potential to be more patient-centric, convenient and efficient. Join our #echalktalk discussion with Dr. Stephen Knowles to learn more: #halozyme #enhanzedrugdeliverytechnology @AAPSComms www.pathlms.com/aaps/account/inactive
-
Halozyme, Inc.
@halozymeinc
Haloyzme Reports 3rd qtr 2021 Results-Record Quarterly Royalties in the 3rd qtr of $58.6 million Representing 145% Growth over 3rd qtr 2020. Visit our investor's site to learn more. ir.halozyme.com/overview/default.aspx www.prnewswire.com/news-releases/halozyme-reports-third-q…
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting Patricia Ann Weigand, our Sr. Administrative Assistant. She shares what she enjoys most about our Halozyme community including our commitment to improving patient experiences. #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
STARTING AT 1:15 pm EDT - Presentation with Michael J. LaBarre, Ph.D., CTO #halozyme Learn about facilitating rapid subQ admin of large volume biologics with #enhanzedrugdeliverytechnology
Register for #podd2021 In-Person + Virtual: reg.theconferenceforum.org/event/podd-2021/ -
Halozyme, Inc.
@halozymeinc
REGISTER NOW for our upcoming #echalktalk Live Webinar & Discussion Nov 10th on the possibilities of large volume SC drug delivery with Dr. Stephen Knowles, Chief Medical Officer at #halozyme #enhanzedrugdeliverytechnology @AAPSComms www.pathlms.com/aaps/account/inactive
-
Halozyme, Inc.
@halozymeinc
STARTING AT 1:15 pm EDT - Presentation with Michael J. LaBarre, Ph.D., CTO #halozyme Learn about facilitating rapid subQ admin of large volume biologics with #enhanzedrugdeliverytechnology
Register for #podd2021 In-Person + Virtual: reg.theconferenceforum.org/event/podd-2021/ -
Halozyme, Inc.
@halozymeinc
Don’t miss it! REGISTER NOW for our #echalktalk Live Webinar & Discussion Nov 10th on the possibilities of large volume SC drug delivery with Dr. Stephen Knowles, Chief Medical Officer at #halozyme www.pathlms.com/aaps/account/inactive
#enhanzedrugdeliverytechnology @AAPSComms -
Halozyme, Inc.
@halozymeinc
At Halozyme, we are building a diverse team who is passionate and committed to having a positive impact on the lives of patients and their families around the world. Learn about our diversity & inclusion efforts here: halozyme.com/responsibility/ #globaldiversityawarenessmonth
-
Halozyme, Inc.
@halozymeinc
Thurs, Oct 28, 1:15 pm EDT Tech presentation with Michael J. LaBarre, Ph.D., CTO #halozyme Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology Register for #podd2021 In-Person + Virtual: reg.theconferenceforum.org/event/podd-2021/
-
Halozyme, Inc.
@halozymeinc
Join us at #podd2021 Don't miss our virtual booth and tech presentation to learn more about how #enhanzedrugdeliverytechnology facilitates rapid SC administration of large volume biologics. #halozyme theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
Halozyme to host its Quarterly Update Conference Call for the third quarter 2021 on November 2 at 4:30 p.m. ET / 1:30 p.m. www.prnewswire.com/news-releases/halozyme-to-host-third-q…
-
Halozyme, Inc.
@halozymeinc
We are building a #diverse team that is committed to improving patients’ lives while operating in a sustainable, socially responsible manner to deliver benefits for patients. We are currently seeking a Sr. Manager Business Development Learn more: halozyme.com/careers/
-
Halozyme, Inc.
@halozymeinc
This #globaldiversityawarenessmonth, we celebrate the #diversity among our Halozyme community & beyond. We are building a team with various backgrounds & traditions who are passionate about revolutionizing drug delivery technology. Learn about our #dei. halozyme.com/responsibility/
-
Halozyme, Inc.
@halozymeinc
In honor of #breastcancerawarenessmonth, we are proud to showcase Christina Hanson Furasek as she shares her experience with breast cancer and how she found silver linings every day. Thank you Christina for bravely sharing your story!
-
Halozyme, Inc.
@halozymeinc
#icymi: Last month, our President & CEO, Helen Torley, presented at the @WellsFargo Virtual Healthcare Conference. Visit our website to watch the replays. ir.halozyme.com/events-and-presentations/events/event-det…
-
Halozyme, Inc.
@halozymeinc
In honor of #worldmentalhealthday, we recognize the importance of prioritizing mental, emotional & physical health. Our team incorporated a week-long summer "Inspire Week" to allow our employees to take a break and nourish both their minds & bodies. halozyme.com/company-updates/inspire-week-highlighting-th…
-
Halozyme, Inc.
@halozymeinc
October is recognized as #breastcancerawareness Month, with the goal of increasing awareness and raising support for research. At Halozyme, our sole focus is to improve treatment options for patients. Join us in raising awareness @BreastCancerNow @BCRFcure
-
Halozyme, Inc.
@halozymeinc
TODAY: 12:30 pm EDT LIVE #pharmsci360 Pre-show webinar with Dr. Stephen Knowles, Chief Medical Officer #halozyme Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology
www.pathlms.com/aaps/account/inactive -
Halozyme, Inc.
@halozymeinc
Thurs, Oct 7, 12:30 pm EDT LIVE #pharmsci360 Pre-show webinar with Dr. Stephen Knowles, Chief Medical Officer #halozyme Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology www.pathlms.com/aaps/account/inactive
-
Halozyme, Inc.
@halozymeinc
Thurs, Oct 7, 12:30 pm EDT LIVE #pharmsci360 Pre-show webinar with Dr. Stephen Knowles, Chief Medical Officer #halozyme Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology
Register: www.pathlms.com/aaps/account/inactive -
Halozyme, Inc.
@halozymeinc
Today our SVP and CFO, Elaine Sun, will present at the @cantorfitzgerald Virtual Global Healthcare Conference. Tune in today at 1:20 p.m. ET / 10:20 a.m. PT. Visit the Investor section of our website to register. ir.halozyme.com/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
Tomorrow, our SVP and CFO, Elaine Sun, will be presenting at the @cantorfitzgerald Virtual Global Healthcare Conference. Tune in on Tuesday, September 28 at 1:20 p.m. ET / 10:20 a.m. PT. Visit the Investor section of our website to register. ir.halozyme.com/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
Our President & CEO, Helen Torley, will be serving as a keynote speaker at the @ASAP_Global BioPharma Conference 2021 alongside @argenxglobal Co-founder & CEO Tim Van Hauwermeiren. Tune in on Mon, Sept. 27, 2021 from 10:20 – 11:20 a.m. ET. #asapvirtual www.strategic-alliances.org/asap-biopharma-conference
-
Halozyme, Inc.
@halozymeinc
We are excited to spotlight Celine Derunes, our Senior Director of Operations Strategy. Celine shares her experience working for Halozyme and how our focus on values shapes the company culture for all employees. #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
Our President & CEO, Helen Torley, will be serving as a keynote speaker at the @ASAP_Global BioPharma Conference 2021 alongside @argenxglobal Co-founder & CEO Tim Van Hauwermeiren. Tune in on Mon, Sept. 27, 2021 from 10:20 – 11:20 a.m. ET. #asapvirtual www.strategic-alliances.org/asap-biopharma-conference
-
Halozyme, Inc.
@halozymeinc
As the Summer season comes to a close, we are looking back at how our Halozyme team enjoyed spending time with loved ones and taking restful vacations. Take a look at how our employees spent their Summer break! #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
Our President & CEO, Helen Torley, will be serving as a keynote speaker at the @ASAP_Global BioPharma Conference 2021 alongside @argenxglobal Co-founder & CEO Tim Van Hauwermeiren. Tune in on Mon, Sept. 27, 2021 from 10:20 – 11:20 a.m. ET. #asapvirtual www.strategic-alliances.org/asap-biopharma-conference
-
Halozyme, Inc.
@halozymeinc
Our team is driven to bring innovative solutions & support to partners with a goal of significantly improving patient experiences, and potentially outcomes, for emerging and established therapies. We are seeking a Manager, Quality GxP Comp Sys Ops halozyme.com/careers/ #hiring
-
Halozyme, Inc.
@halozymeinc
Halozyme's senior vice president and chief financial officer, Elaine Sun will present at the 2021 Cantor Virtual Global Healthcare Conference on 9/28.ir.halozyme.com/events-and-presentations/events/default.aspx
-
Halozyme, Inc.
@halozymeinc
Today marks the beginning of National Hispanic Heritage Month recognizing contributions and influence Hispanic Americans made to our country’s history, culture and achievements. We honor this month as we continue to build a diverse and inclusive team. #hispanicheritagemonth
-
Halozyme, Inc.
@halozymeinc
Tomorrow, our President & CEO, Helen Torley, will be presenting at the @WellsFargo 2021 Virtual Healthcare Conference. Tune in on Fri, Sept. 10th at 10:40 a.m. ET / 7:40 a.m. PT. Visit the Investor section of our website to register. ir.halozyme.com/events-and-presentations/events/event-det…
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting Lewis Adams, Warehouse Lead for Halozyme. Lewis brings over 30 years of experience to Halozyme and shares why he enjoys working for Halozyme.
-
Halozyme, Inc.
@halozymeinc
We recently launched a new Halozyme corporate website and invite you to check it out: halozyme.com #websitelaunch #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology breaks traditional subQ volume barriers to facilitate rapid high-dose, high-volume subQ administration. Learn how we do it learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
Today is #womensequalityday! One of our core values is ‘We Respect and Value the Team’ meaning we strive to build a welcoming & inclusive workplace. Our team recognizes all the women who make up Halozyme’s team and thank them for the work they do to drive our mission forward
-
Halozyme, Inc.
@halozymeinc
Halozyme to Present at Wells Fargo 2021 Virtual Healthcare Conference www.prnewswire.com/news-releases/halozyme-to-present-at-w…
-
Halozyme, Inc.
@halozymeinc
Today, our VP of Human Resources, Amy Fox, will be speaking at the University Lab Partners (@ulpirvine) event series entitled “OC LIFe – Recruiting for Emerging Life Science Companies.” Tune in on Wed, Aug. 25 from 3:00 – 4:00 p.m. PT. Register here: us02web.zoom.us/webinar/register/WN_bhgPAl9WRcqz5EkU19Z1Rg
-
Halozyme, Inc.
@halozymeinc
Tomorrow, our VP of Human Resources, Amy Fox, will be speaking at the University Lab Partners (@ulpirvine) event series entitled “OC LIFe – Recruiting for Emerging Life Science Companies.” Tune in on Wed, Aug. 25 from 3:00 – 4:00 p.m. PT. Register here: us02web.zoom.us/webinar/register/WN_bhgPAl9WRcqz5EkU19Z1Rg
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology is globally validated to facilitate the subQ admin of five approved therapeutics. Will yours be next? Learn more and see the MoA video learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
Thursday, September 9 at 3 p.m. EDT—Join David W. Kang for a webinar and LIVE Q&A discussing rapid, large volume SC drug delivery using #enhanzedrugdeliverytechnology. Register here: attendee.gotowebinar.com/register/2224147510540701953?sou…
-
Halozyme, Inc.
@halozymeinc
WEBINAR: Learn more about high-dose, high-volume SC drug delivery using #enhanzedrugdeliverytechnology on Thursday, September 9 from 3:00-3:30 p.m. EDT. with David W. Kang of @halozymeinc Register today: attendee.gotowebinar.com/register/2224147510540701953?sou…
-
Halozyme, Inc.
@halozymeinc
We are a team of #diverse individuals committed to bringing results to bring innovative and disruptive solutions that improve the patient experience. We are seeking a Manager, Drug Product Manufacturing. Learn more here: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs #hiring
-
Halozyme, Inc.
@halozymeinc
As a leading biopharma company, we are building a diverse team who is committed to making a positive impact on the lives of patients & their families. We are looking for individuals with unique talents & backgrounds to join our team. View our careers page: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs
-
Halozyme, Inc.
@halozymeinc
Earlier this week we announced our second quarter 2021 financial results and corporate business updates. Learn more about our recent progress and upcoming milestones: halozyme.com/investors/news-releases/news-release-details… $HALO
-
Halozyme, Inc.
@halozymeinc
Halozyme Reports Second Quarter Results www.prnewswire.com/news-releases/halozyme-reports-second-…
-
Halozyme, Inc.
@halozymeinc
In honor of #nationalwellnessmonth, we are looking back at “Inspire Week” – a week long summer reset which allowed our employees to take a break from work and prioritize quality time with loved ones. Our team has shared the many ways they relaxed and recharged during their break.
-
Halozyme, Inc.
@halozymeinc
Faster admin. Conversion of IV to subQ. Large subQ volumes. Learn about the potential benefits of co-administration #enhanzedrugdeliverytechnology Learn more about the subQ possibilities of partnership with ENHANZE technology. learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference on August 11th at 3:30pm ET @CanaccorGenuity #halozyme www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call on August 9th at 1:30pm PT please use this link to register: www.directeventreg.com/registration/event/5694076 www.prnewswire.com/news-releases/halozyme-to-host-second-…
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology breaks traditional subQ volume barriers to facilitate rapid high-dose, high-volume subQ administration. Learn how we do it learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
We’re excited to welcome #crs2021 attendees today to our Tech Forum on the SC patient experience, Patient-Centric SC 1st Strategies in Advanced Drug Development. Join us today at 12pm EDT! #halozyme #enhanzedrugdeliverytechnology @CRSScience 2021.controlledreleasesociety.org/halozyme-therapeutics.html
-
Halozyme, Inc.
@halozymeinc
We’re excited to welcome #crs2021 attendees today to our Tech Forum on the SC patient experience, Patient-Centric SC 1st Strategies in Advanced Drug Development. Join us today at 12pm EDT! #halozyme #enhanzedrugdeliverytechnology @CRSScience 2021.controlledreleasesociety.org/halozyme-therapeutics.html
-
Halozyme, Inc.
@halozymeinc
This month, we are spotlighting a valuable member of our team – Aamara De Los Reyes, Senior Human Resources Generalist. Aamara shares her experience working for Halozyme and being a part of our workplace culture! #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology is globally validated to facilitate the subQ admin of five approved therapeutics. Will yours be next? Learn more and see the MoA video learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
Halozyme is hiring! We are a team of #diverse inviduals committed to bringing results to bring innovative and disruptive solutions that improve the patient experience. We are seeking a Manager of Regulatory Affairs. Learn more here: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs
-
Halozyme, Inc.
@halozymeinc
Are you registered for @CRSScience ? Sign up now for the #enhanzedrugdeliverytechnology Tech Forum—Patient-Centric SC 1st Strategies in Advanced Drug Development—on July 26th at 12pm EDT to hear directly from a patient on her SC story. #halozyme 2021.controlledreleasesociety.org
-
Halozyme, Inc.
@halozymeinc
Are you registered for #crs2021? Sign up now and don't miss the #enhanzedrugdeliverytechnology Tech Forum—Patient-Centric SC 1st Strategies in Advanced Drug Development —on July 26 to hear directly from a patient on her SC story. 2021.controlledreleasesociety.org/halozyme-therapeutics.html
-
Halozyme, Inc.
@halozymeinc
One of our core values is: We Are All Empowered and Accountable — meaning we are flexible and work together to fulfill our commitments to patients, partners, shareholders and to each other. Find out more here: halozyme.com/about/Our-Values/default.aspx
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combo. with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
Faster admin. Conversion of IV to subQ. Large subQ volumes. Learn about the potential benefits of co-administration #enhanzedrugdeliverytechnology Learn more about the subQ possibilities of partnership with ENHANZE technology learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
Happy 4th of July from the Halozyme team! We hope you all are having a wonderful holiday weekend with friends, family and loved ones. #happy4th
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology breaks traditional subQ volume barriers to facilitate rapid high-dose, high-volume subQ administration. Learn how we do it learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
We will be instituting an “Inspire Week” June 29 - July 5 to allow our employees to take a break from their screens to reset and draw inspiration from their lives outside of work. Learn more here: www.linkedin.com/feed/update/urn:li:activity:681532304263…
-
Halozyme, Inc. reposted
GSK
@GSK
#news for #investors and #media: Today’s new collaboration announcement with Halozyme, Inc. keeps us at the forefront of developing innovative new options for HIV treatment and prevention. More information on www.gsk.com
-
Halozyme, Inc.
@halozymeinc
Last Thursday, our President & CEO, Helen Torley spoke on a @statnews panel during the @BIOConvention to discuss key themes from the current landscape of the biotech industry. Listen to the full panel here: www.statnews.com/2021/06/17/virtual-event-biotech-where-a…
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Janssen Receives Two New European Marketing Authorizations for DARZALEX® (daratumumab) Subcutaneous www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology is globally validated to facilitate the subQ admin of five approved therapeutics. Will yours be next? Learn more and see the MoA video learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of “ultra-long-acting” medicines for HIV www.prnewswire.com/news-releases/viiv-healthcare-and-halo…
-
Halozyme, Inc.
@halozymeinc
In honor of #juneteenth, we are celebrating this historic holiday which marks the end of slavery in the United States. At Halozyme, we commemorate Black history and culture by fostering a diverse and #inclusive work environment. View more resources here: juneteenth.com/welcome.htm
-
Halozyme, Inc.
@halozymeinc
We are building a team of passionate and committed people that want to have a positive impact on the lives of patients and their families around the world.
Hear from Tiffany Coles, Director, Drug Safety & Pharmacovigilance on her experience at Halozyme. #wearehalozyme -
Halozyme, Inc.
@halozymeinc
At Halozyme, our core values drive our commitment to provide safe and effective therapies to patients by continuously bringing innovative and disruptive drug delivery solutions. Learn more here: halozyme.com/careers/our-mission/default.aspx #ourvalues
-
Halozyme, Inc.
@halozymeinc
Faster admin. Conversion of IV to subQ. Large subQ volumes. Learn about the potential benefits of co-administration #enhanzedrugdeliverytechnology Learn more about the subQ possibilities of partnership with ENHANZE technology. learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
It's #nationalcancersurvivorsday – we are celebrating those who have survived cancer & gathering support for families who continue to be impacted by cancer. At Halozyme, our ENHANZE® technology has the potential to reduce treatment administration times. halozyme.com/enhanze/pipeline/default.aspx
-
Halozyme, Inc.
@halozymeinc
June is #pridemonth! Here at Halozyme, we are celebrating the #lgbtq community with pride and supporting our diverse employee community. This month, and every month, we value and celebrate the unique talents, backgrounds and perspectives each employee brings to #halozyme
-
Halozyme, Inc.
@halozymeinc
#halozyme announces data presentations by #collaborators for therapies utilizing #enhanze #asco21 @roche @JanssenUS @bmsnews www.prnewswire.com/news-releases/halozyme-highlights-data…
-
Halozyme, Inc.
@halozymeinc
Halozyme to Present @GoldmanSachs 42nd Annual Global Healthcare Conference and JMP Securities Life Sciences Conference. To learn more halozyme.com/newsroom/news-releases/default.aspx
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology is globally validated to facilitate the subQ admin of five approved therapeutics. Will yours be next? Learn more and see the MoA video: learn.enhanze.com/signup-welcome-moa-li
-
Halozyme, Inc.
@halozymeinc
We continue to value and celebrate our employees and their unique talents, backgrounds and perspectives each brings to Halozyme. We are highlighting Tara Nekoroski, our Associate Director, Bioanalytical Development Group, on her experience at Halozyme. #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Janssen Receives Two Positive CHMP Opinions for DARZALEX® (daratumumab) Subcutaneous Formulation Utilizing ENHANZE® www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
Learn how our patented rHuPH20 enzyme may help improve the patient experience. #enhanzedrugdeliverytechnology #halozyme @AAPSComms #nbc2021 Click here to learn more: learn.enhanze.com/signup-welcome-moa-nbc/
-
Halozyme, Inc.
@halozymeinc
JOIN US NOW 3:30 pm EST - LIVE PRESENTATION Discover how our patented rHuPH20 enzyme may help reduce administration time from IV. 5-15mL in ~5 min (based on commercially approved products). David W. Kang #halozyme @AAPSComms Register #nbc2021 Register: www.aaps.org/nbc
-
Halozyme, Inc.
@halozymeinc
Today @ 2:15 pm EST - Presentation by Michael LaBarre, Ph.D., Chief Technology Officer #halozyme Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology Register for #drugdeliverywest Virtual: www.drugdeliverywest.org
-
Halozyme, Inc.
@halozymeinc
Today @2:15 pm EST - Presentation by Michael LaBarre, Ph.D., Chief Technology Officer #halozyme Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology Register for #drugdeliverywest VIRTUAL: www.drugdeliverywest.org
-
Halozyme, Inc.
@halozymeinc
Starting @ 3:30 pm EST - Live roundtable presentation w/ David W. Kang, Associate Director #halozyme Learn about facilitating rapid subQ administration of large volume biologics w/ #enhanzedrugdeliverytechnology @AAPSComms
Register #nbc2021 Virtual: www.aaps.org/nbc -
Halozyme, Inc.
@halozymeinc
On Mon. May 17 @2:15 pm EST Michael LaBarre, Ph.D., Chief Technology Officer #halozyme will present on facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology Register for #drugdeliverywest
www.drugdeliverywest.org -
Halozyme, Inc.
@halozymeinc
Mon, May 17, 3:30 pm EST Live roundtable presentation with David W. Kang, Associate Director #halozyme Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology @AAPSComms Register for #nbc2021 www.aaps.org/nbc
-
Halozyme, Inc.
@halozymeinc
On Mon. May 17 @2:15 pm EST Michael LaBarre, Ph.D., Chief Technology Officer #halozyme will present on facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology Register for #drugdeliverywest
www.drugdeliverywest.org -
Halozyme, Inc.
@halozymeinc
This week is National Women’s Health Week, highlighting the importance for women to make health a priority and take care of their body and mind. At Halozyme, the health of our patients is a driving part of our mission as we are committed to improving drug delivery options. #nwhw
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology can support your drug development. Its breaking traditional subQ volume barriers, enabling bulk fluid flow & increasing dispersion and absorption of subQ administered drugs.
#halozyme #drugdeliverywest
Schedule a time - drugdeliverywest.meeting-mojo.com -
Halozyme, Inc.
@halozymeinc
This month, we continue to support #mentalhealthmonth by spreading awareness of the importance of providing education for mental health. Join us as we support @MentalHealthAm and learn more here: mhanational.org/mental-health-month/
-
Halozyme, Inc.
@halozymeinc
Halozyme Reports First Quarter 2021 Results www.prnewswire.com/news-releases/halozyme-reports-first-q…
-
Halozyme, Inc.
@halozymeinc
Learn how #enhanzedrugdeliverytechnology facilitates subQ drug administration. Commercially validated with regulatory approvals globally. #halozyme #drugdeliverywest Sign up to learn more: learn.enhanze.com/signup-welcome-moa-ddw/
-
Halozyme, Inc.
@halozymeinc
Discover how our patented rHuPH20 enzyme may help improve the patient experience. #enhanzedrugdeliverytechnology #halozyme #drugdeliverywest Sign up to learn more: learn.enhanze.com/signup-welcome-moa-ddw/
-
Halozyme, Inc.
@halozymeinc
Wishing a wonderful Mother’s Day to all of the mothers that make up our Halozyme team! Today, we are spotlighting our very own Nicole LaBrosse and her family. Thank you for all that you do for your family, community and workplace. #happymothersday
-
Halozyme, Inc.
@halozymeinc
#enhanzedrugdeliverytechnology with our patented enzyme rHuPH20 is facilitating large volume subQ injections (up to 15mL). #halozyme #drugdeliverywest See its unique MoA here: learn.enhanze.com/signup-welcome-moa-ddw/
-
Halozyme, Inc.
@halozymeinc
Mon, May 17 @ 3:30 pm EST Learn how our patented rHuPH20 enzyme may help reduce administration time from IV. 5-15mL in ~5 min (based on commercially approved products). Presentation by David W. Kang #halozyme @AAPSComms Register for #nbc2021
www.aaps.org/nbc -
Halozyme, Inc.
@halozymeinc
Learn how #enhanzedrugdeliverytechnology facilitates subQ drug administration. Commercial validation and regulatory approvals globally.
#halozyme #drugdeliverywest
Click to learn more: www.drugdeliverywest.org -
Halozyme, Inc.
@halozymeinc
-
Halozyme, Inc.
@halozymeinc
We are spotlighting Christopher Bryant, Ph.D., SVP, Technical Operations & Chief Manufacturing Officer of Halozyme. Christopher brings 30+ years of experience in the research, development and approval of numerous marketed therapeutics. Welcome to the team, Chris!
-
Halozyme, Inc.
@halozymeinc
We are building a diverse team who is passionate about & committed to having a positive impact on the lives of patients and their families. We value & celebrate the unique talents, backgrounds and perspectives of each employee. Hear from Wande regarding our team's culture.
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO HOST FIRST QUARTER 2021 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL
www.prnewswire.com/news-releases/halozyme-to-host-first-q… -
Halozyme, Inc.
@halozymeinc
Our CMO, Steve Knowles, recently shared insights on implementing drug safety protocols effectively in an article on Clinical Leader. We are happy to share that this article has been featured in the April edition of the @LifeSciLeader1 magazine. Read here: www.lifescienceleader.com/doc/how-small-biotechs-can-impl…
-
Halozyme, Inc.
@halozymeinc
In honor of #worldhealthday, Halozyme is continuing to encourage all employees to live a happier and healthier lifestyle. Join us in our commitment to building a culture focused on strong mental and physical health for all employees!
-
Halozyme, Inc.
@halozymeinc
April is #nationalminorityhealthmonth – focused on promoting educational efforts on health problems facing minority populations. We continue to support diversity within our industry. halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
We’re hiring! Halozyme is looking to expand our team and build a collaborative environment with a shared mission to expand treatment options for patients in need. Interested in joining the team? See our opportunities here: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs
-
Halozyme, Inc.
@halozymeinc
We are committed to the highest standards of Environmental, Social & Governance performance. This includes ensuring a healthy environment that is committed to diversity & inclusion and protects the well-being of all employees. View our #esg brochure here: halozyme.com/investors/Commitment-to-ESG/default.aspx
-
Halozyme, Inc.
@halozymeinc
One of our core values is: We Focus on Patients. This means we are committed to putting the patient first by prioritizing and optimizing the treatment experience for patients and their families. Learn more here: halozyme.com/careers/our-mission/default.aspx
-
Halozyme, Inc.
@halozymeinc
Hear from our vice president of human resources, Amy Fox, on the importance of #womenshistorymonth and how Halozyme continues to prioritize gender diversity at all levels of the company.
-
Halozyme, Inc.
@halozymeinc
In honor of #myelomaawarenessmonth, we would like to spotlight our ENHANZE® technology collaboration with @JanssenGlobal in furthering treatment options in multiple myeloma. We are proud to play a part in the fight against multiple myeloma for patients and their families.
-
Halozyme, Inc.
@halozymeinc
In case you missed it: Our president & CEO Helen Torley presented a 2021 corporate update at the @jpmorgan Virtual Healthcare Conference in January. Visit our Events & Webcasts page to stay up-to-date on all activities. halozyme.com/investors/events-and-webcast/event-details/2…
-
Halozyme, Inc.
@halozymeinc
Now more than ever, it is important to prioritize our #health and #wellness. This month, our Halozyme team is participating company-wide @fitbit health challenge to bring everyone together in friendly competition for fitness. Look forward to seeing who reigns victorious!
-
Halozyme, Inc.
@halozymeinc
Our ENHANZE® technology has been able to reduce standard infusion times from hours to minutes – helping to improve patient experiences. Learn more about how we’re working with #biopharma companies to reduce infusion times: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
Halozyme Reports Fourth Quarter and Full Year 2020 Financial Results www.prnewswire.com/news-releases/halozyme-reports-fourth-…
-
Halozyme, Inc.
@halozymeinc
We’re hiring! Halozyme is looking to expand our team and build a collaborative environment with a shared mission to expand treatment options for patients in need. Join top-tier talent in 2021! See our opportunities here: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs
-
Halozyme, Inc.
@halozymeinc
We believe that #diversity in all aspects of business operations will optimize the continued growth and success of our company and the biotechnology industry. Learn more about our diversity and inclusion principles here: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
In honor of #nationalcancerpreventionmonth, we are paying tribute to all individuals and families who are affected by cancer. Many types of #cancer are more treatable when caught in the early stages, improving patients’ chances of recovery. Join us in spreading awareness!
-
Halozyme, Inc.
@halozymeinc
February is #blackhistorymonth which recognizes the generations of African Americans who have struggled with adversity and continue to fight for equality. Join us as we continue to pay tribute to this observance month and prioritize diversity in the workplace.
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO HOST FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL www.prnewswire.com/news-releases/halozyme-to-host-fourth-…
-
Halozyme, Inc.
@halozymeinc
Hear from our chief medical officer, Steve Knowles, on how to implement drug safety protocols effectively in his recent article titled ”You’re A Small Biotech — How Should You Implement A Pharmacovigilance System?” on @LifeSciLeader1. Read more here: www.clinicalleader.com/doc/you-re-a-small-biotech-how-sho…
-
Halozyme, Inc.
@halozymeinc
Are you looking to partner your program with our drug delivery technology? For more information on partnering with Halozyme, please contact a member of the business development team here: halozyme.com/partnering/opportunities/default.aspx
-
Halozyme, Inc.
@halozymeinc
Our primary technology is based on a proprietary enzyme that degrades hyaluronan (HA) locally and transiently. Learn more about our science and how we use the rHuPH20 enzyme to co-develop subcutaneous products: halozyme.com/science/the-role-of-hyaluronan-ha/ha-in-the-…
-
Halozyme, Inc.
@halozymeinc
Today we honor the life and legacy of Dr. Martin Luther King Jr. whose mission of championing #equality and eliminating discrimination serve as a continued example of justice #mlkday
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES JANSSEN RECEIVES FDA APPROVAL OF DARZALEX FASPRO® (DARATUMUMAB AND HYALURONIDASE-FIHJ) AS TREATMENT FOR NEWLY DIAGNOSED PATIENTS WITH LIGHT CHAIN (AL) AMYLOIDOSIS www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
Our vice president of global partnering, Renee Tannenbaum, was featured in @LifeSciLeader1 to discuss “5 Elements Of A Long-Term Partnership Strategy” – highlighting how to create a meaningful
partnership that brings lasting value. Read more here: www.lifescienceleader.com/doc/elements-of-a-long-term-par… -
Halozyme, Inc.
@halozymeinc
As we enter a new year in 2021, our team at Halozyme is reminded of our core values – driving our mission to bring innovative and disruptive solutions that improve the patient experience. Learn more here: halozyme.com/about/Our-Values/default.aspx #ourvalues
-
Halozyme, Inc.
@halozymeinc
This week is the beginning of the virtual #jpmorgan2021 Healthcare Conference. We look forward to attending the event virtually and connecting with investors. #jpm21
-
Halozyme, Inc.
@halozymeinc
HALOZYME PROVIDES 2021 FINANCIAL GUIDANCE HIGHLIGHTED BY STRONG REVENUE AND EPS GROWTH www.prnewswire.com/news-releases/halozyme-provides-2021-f…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PRESENT VIRTUALLY AT THE 39TH ANNUAL
J.P. MORGAN HEALTHCARE CONFERENCE www.prnewswire.com/news-releases/halozyme-to-present-virt… -
Halozyme, Inc.
@halozymeinc
Happy New Year from our team at Halozyme! Wishing everyone a happy and healthy 2021.
-
Halozyme, Inc.
@halozymeinc
Our team at Halozyme would like to wish you all a very happy holiday season! We hope you and your family are continuing to stay safe and well.
-
Halozyme, Inc.
@halozymeinc
Our employees have been busy doing what they love best this holiday season: Giving back to the community! Along with the @BGCGSD, Halozyme employees participated in a Thanksgiving food drive and an Adopt-A-Family Holiday gift drive providing food and gifts to families in need!
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES ROCHE RECEIVES EUROPEAN COMMISSION APPROVAL FOR PHESGO® (FIXED-DOSE COMBINATION OF PERJETA® AND HERCEPTIN® ) www.prnewswire.com/news-releases/halozyme-announces-roche…
-
Halozyme, Inc.
@halozymeinc
Don’t forget to stay up to date on all Halozyme news and activity by visiting our virtual newsroom for our most recent corporate updates: halozyme.com/newsroom/news-releases/default.aspx
-
Halozyme, Inc.
@halozymeinc
One of our core values is: We Are All Empowered and Accountable. This means we work together to overcome challenges in order to fulfill our commitment to patients, partners and each other. Learn more here: halozyme.com/careers/our-mission/default.aspx
-
Halozyme, Inc.
@halozymeinc
We value #diversity in all aspects of our business operations & continue to build a diverse team who is passionate about having a positive impact on the lives of patients around the world. Learn more about our diversity and inclusion principles here: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
Are you interested in the opportunity to work with professionals to bring disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies? Halozyme is looking for top-tier talent, view open positions: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs
-
Halozyme, Inc.
@halozymeinc
Happy Thanksgiving from your friends at Halozyme! Wishing everyone a happy, safe and food-filled holiday.
-
Halozyme, Inc.
@halozymeinc
Do you know all of the benefits of our ENHANZE drug delivery technology? Read the full list of ways our technology improves patient experience in this digital brochure: s21.q4cdn.com/250105458/files/doc_downloads/2018/ENZ18009…
-
Halozyme, Inc.
@halozymeinc
HALOZYME RAISES FULL YEAR 2020 GUIDANCE www.prnewswire.com/news-releases/halozyme-raises-full-yea…
-
Halozyme, Inc.
@halozymeinc
Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology www.prnewswire.com/news-releases/horizon-therapeutics-plc…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PARTICIPATE IN FIRESIDE CHAT FOR THE PIPER SANDLER 32ND ANNUAL VIRTUAL HEALTHCARE CONFERENCE www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
At Halozyme, our primary technology is based on its proprietary recombinant human hyaluronidase PH20 enzyme (rHuPH20) that degrades hyaluronan, or HA. Learn more about the role of HA it in the subcutaneous space: halozyme.com/science/the-role-of-hyaluronan-ha/ha-in-the-…
-
Halozyme, Inc.
@halozymeinc
In honor of #nationalfamilycaregiversmonth, we’re recognizing the contributions of caregivers everywhere – you are all an important component of patient recovery. Thank you for all that you do!
-
Halozyme, Inc.
@halozymeinc
It’s #worldkindnessday! We’re proud of our company values that encourage positivity and kindness throughout our organization – such as respecting the team, focusing on patients and doing the right thing. Read more about our values on our website: halozyme.com/about/Our-Values/default.aspx
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES JANSSEN SUBMISSION OF APPLICATIONS IN US AND EU SEEKING APPROVAL OF DARZALEX FASPRO™/ DARZALEX® SUBCUTANEOUS (SC) FORMULATION UTILIZING ENHANZE® TECHNOLOGY, COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
Want to hear the latest about our work to improve patient experiences and outcomes? Stay apprised of the latest through our Newsroom: halozyme.com/newsroom/news-releases/default.aspx
-
Halozyme, Inc.
@halozymeinc
Tell us about your subQ drug development needs. Take our Rapid Feedback Survey. #enhanzedrugdeliverytechnology #halozymetherapeutics www.surveymonkey.com/r/HalozymeAAPS #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Ready to improve the patient treatment experience with rapid high-dose, high-volume subQ drug delivery? #enhanzedrugdeliverytechnology with the patented rHuPH20 enzyme from #halozymetherapeutics is ready to help. Email bd4@Halozyme.com to discuss. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology patented rHuPH20 enzyme. #halozymetherapeutics @AAPSComms See how it works: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
November is American Indian & Alaska Native Heritage Month! To honor the importance of the month, we want to take a moment and celebrate #diverse cultures, traditions, and histories and acknowledge the significant contributions of #native people.
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE view abstract by David W. Kang Senior Research Scientist, and learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology. #halozymetherapeutics @AAPSComms View abstract here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B…
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology with our patented rHuPH20 enzyme facilitates rapid high-dose, high-volume subQ drug administration. Commercial validation & regulatory approvals globally. #halozymetherapeutics Email bd4@Halozyme.com to schedule a time. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES UPCOMING DATA PRESENTATIONS AT AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING FOR APOLLO AND ANDROMEDA PHASE 3 STUDIES BY JANSSEN EVALUATING SUBCUTANEOUS DARATUMUMAB UTILIZING ENHANZE® www.prnewswire.com/news-releases/halozyme-announces-upcom…
-
Halozyme, Inc.
@halozymeinc
Are you working to develop subQ biologics? What are the key challenges and considerations in deciding to develop subQ drugs? Take the Rapid Feedback Survey: www.surveymonkey.com/r/HalozymeAAPS #enhanzedrugdeliverytechnology #halozymetherapeutics #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE see how #halozymetherapeutics #enhanzedrugdeliverytechnology patented rHuPH20 enzyme can facilitate subQ drug administration. 5-15mL in ~5 min (based on commercially approved products). View abstract here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B…
@AAPSComms -
Halozyme, Inc.
@halozymeinc
Breaking barriers to traditional subQ & IV drug delivery volume limitations, slow delivery speeds, & health system costs with #enhanzedrugdeliverytechnology. #halozymetherapeutics. Schedule a 1-on-1 discussion. Email bd4@Halozyme.com #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Our ultimate goal is improving patient treatment experiences. Learn more about our patented rHuPH20 enzyme at #pharmsci360 ONLINE by viewing poster by David W. Kang Senior Research Scientist, SC Drug Delivery here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B… @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Ready to improve the patient treatment experience with rapid high-dose, high-volume subQ drug delivery? #enhanzedrugdeliverytechnology with the patented rHuPH20 enzyme from #halozymetherapeutics is ready to help. Email bd4@Halozyme.com to discuss. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Tell us about your subQ drug development needs. Take our Rapid Feedback Survey. #enhanzedrugdeliverytechnology #halozymetherapeutics www.surveymonkey.com/r/HalozymeAAPS #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology patented rHuPH20 enzyme. #halozymetherapeutics @AAPSComms See how it works: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology with our patented rHuPH20 enzyme facilitates rapid high-dose, high-volume subQ drug administration. Commercial validation & regulatory approvals globally. #halozymetherapeutics Email bd4@Halozyme.com to schedule a time. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE discover how #enhanzedrugdeliverytechnology facilitates rapid subQ administration of large volume biologics. #halozymetherapeutics. View abstract by David W. Kang Senior Research Scientist, SC Drug Delivery here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B… @AAPSComms
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology with rHuPH20 MoA depolymerizes hyaluronan to help overcome subQ volume limitations. Can it support the development of your subQ formulations? #halozymetherapeutics Email bd4@Halozyme.com to schedule a 1-on-1 discussion. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Are you working to develop subQ biologics? What are the key challenges and considerations in deciding to develop subQ drugs? Take the Rapid Feedback Survey: www.surveymonkey.com/r/HalozymeAAPS #enhanzedrugdeliverytechnology #halozymetherapeutics #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Today we’re excited to present the results of our Q3 earnings. Check out the press release for details or tune in to the webcast to hear from our CEO Helen Torley: halozyme.com/investors/news-releases/news-release-details…
-
Halozyme, Inc.
@halozymeinc
HALOZYME REPORTS THIRD QUARTER 2020 RESULTS AND RAISES FULL YEAR 2020 GUIDANCE www.prnewswire.com/news-releases/halozyme-reports-third-q…
-
Halozyme, Inc.
@halozymeinc
OCT 26-NOV 5 #pharmsci360 ONLINE learn how #enhanzedrugdeliverytechnology— validated through multiple approvals by global regulatory authorities—facilitates subQ drug delivery. #halozymetherapeutics Poster by David Kang Sr Research Scientist: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B… @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Breaking barriers to traditional subQ & IV drug delivery volume limitations, slow delivery speeds, & health system costs with #enhanzedrugdeliverytechnology. #halozymetherapeutics. Schedule a 1-on-1 discussion. Email bd4@Halozyme.com #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE learn how #enhanzedrugdeliverytechnology rHuPH20 enzyme may help improve patient treatment experiences by enabling rapid subQ delivery of high-dose, high-volume drugs. #halozymetherapeutics @AAPSComms See how it works: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
Can #enhanzedrugdeliverytechnology support your drug development? We're breaking traditional volume barriers, enabling bulk fluid flow, increasing dispersion & absorption of subQ administered drugs. Email bd4@Halozyme.com to discuss. #halozymetherapeutics #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE view abstract by David W. Kang Senior Research Scientist, and learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology. #halozymetherapeutics @AAPSComms View abstract here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B…
-
Halozyme, Inc.
@halozymeinc
Our Chief Financial Officer, Elaine Sun, shares her view on how Halozyme prioritizes diversity in the workplace. #globaldiversityawarenessmonth
-
Halozyme, Inc.
@halozymeinc
Tell us about your subQ drug development needs. Take our Rapid Feedback Survey. #enhanzedrugdeliverytechnology #halozymetherapeutics www.surveymonkey.com/r/HalozymeAAPS #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Renee Tannenbaum, vice president of Global Partnering, discusses how she incorporates diversity and inclusion into our strategic partnerships. #globaldiversityawarenessmonth
-
Halozyme, Inc.
@halozymeinc
Breaking barriers to traditional subQ & IV drug delivery volume limitations, slow delivery speeds, & health system costs with #enhanzedrugdeliverytechnology. #halozymetherapeutics. Schedule a 1-on-1 discussion. Email bd4@Halozyme.com #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE see how #halozymetherapeutics #enhanzedrugdeliverytechnology patented rHuPH20 enzyme can facilitate subQ drug administration. 5-15mL in ~5 min (based on commercially approved products). View abstract here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B…
@AAPSComms -
Halozyme, Inc.
@halozymeinc
As Global Diversity Awareness Month comes to an end, we are continuing our mission to build a diverse team who is passionate about having a positive impact on the lives of patients and their families around the world. Let’s continue the conversation for increased diversity!
-
Halozyme, Inc.
@halozymeinc
Are you working to develop subQ biologics? What are the key challenges and considerations in deciding to develop subQ drugs? Take the Rapid Feedback Survey: www.surveymonkey.com/r/HalozymeAAPS #enhanzedrugdeliverytechnology #halozymetherapeutics #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology with our patented rHuPH20 enzyme facilitates rapid high-dose, high-volume subQ drug administration. Commercial validation & regulatory approvals globally. #halozymetherapeutics Email bd4@Halozyme.com to schedule a time. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Ready to improve the patient treatment experience with rapid high-dose, high-volume subQ drug delivery? #enhanzedrugdeliverytechnology with the patented rHuPH20 enzyme from #halozymetherapeutics is ready to help. Email bd4@Halozyme.com to discuss. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Our ultimate goal is improving patient treatment experiences. Learn more about our patented rHuPH20 enzyme at #pharmsci360 ONLINE by viewing poster by David W. Kang Senior Research Scientist, SC Drug Delivery here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B… @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Hear more thoughts on our diversity and inclusion for #globaldiversityawarenessmonth from Becky Tanamachi, executive director of Manufacturing and Supply Chain Operation.
-
Halozyme, Inc.
@halozymeinc
Tell us about your subQ drug development needs. Take our Rapid Feedback Survey. #enhanzedrugdeliverytechnology #halozymetherapeutics www.surveymonkey.com/r/HalozymeAAPS #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology patented rHuPH20 enzyme. #halozymetherapeutics @AAPSComms See how it works: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology with our patented rHuPH20 enzyme facilitates rapid high-dose, high-volume subQ drug administration. Commercial validation & regulatory approvals globally. #halozymetherapeutics Email bd4@Halozyme.com to schedule a time. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology with rHuPH20 MoA depolymerizes hyaluronan to help overcome subQ volume limitations. Can it support the development of your subQ formulations? #halozymetherapeutics Email bd4@Halozyme.com to schedule a 1-on-1 discussion. #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE discover how #enhanzedrugdeliverytechnology facilitates rapid subQ administration of large volume biologics. #halozymetherapeutics. View abstract by David W. Kang Senior Research Scientist, SC Drug Delivery here: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B… @AAPSComms
-
Halozyme, Inc.
@halozymeinc
We have value-driving partnerships with leading pharmaceutical and biotechnology companies for our ENHANZE® drug delivery technology. To learn more about our partners and business development opportunities, visit our partnering page: halozyme.com/partnering/enhanze-technology-partners/defau…
-
Halozyme, Inc.
@halozymeinc
OCT 26-NOV 5 #pharmsci360 ONLINE learn how #enhanzedrugdeliverytechnology— validated through multiple approvals by global regulatory authorities—facilitates subQ drug delivery. #halozymetherapeutics Poster by David Kang Sr Research Scientist: www.eventscribe.com/2020/PharmSci360/fsPopup.asp?efp=Rk5B… @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Breaking barriers to traditional subQ & IV drug delivery volume limitations, slow delivery speeds, & health system costs with #enhanzedrugdeliverytechnology. #halozymetherapeutics. Schedule a 1-on-1 discussion. Email bd4@Halozyme.com #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Are you working to develop subQ biologics? What are the key challenges and considerations in deciding to develop subQ drugs? Take the Rapid Feedback Survey: www.surveymonkey.com/r/HalozymeAAPS #enhanzedrugdeliverytechnology #halozymetherapeutics #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
Can #enhanzedrugdeliverytechnology support your drug development? We're breaking traditional volume barriers, enabling bulk fluid flow, increasing dispersion & absorption of subQ administered drugs. Email bd4@Halozyme.com to discuss. #halozymetherapeutics #pharmsci360 @AAPSComms
-
Halozyme, Inc.
@halozymeinc
At #pharmsci360 ONLINE learn how #enhanzedrugdeliverytechnology rHuPH20 enzyme may help improve patient treatment experiences by enabling rapid subQ delivery of high-dose, high-volume drugs. #halozymetherapeutics @AAPSComms See how it works: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
Our Senior Director of Manufacturing and Supply Chain Operations Ebin Lanfried shares Halozyme’s commitment to building a diverse workplace. #globaldiversityawarenessmonth
-
Halozyme, Inc.
@halozymeinc
More thoughts on #diversity from Chief of Staff Todd Butler to celebrate #globaldiversityawarenessmonth.
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO HOST THIRD QUARTER 2020 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL www.prnewswire.com/news-releases/halozyme-to-host-third-q…
-
Halozyme, Inc.
@halozymeinc
Hear more thoughts on our diversity and inclusion for #globaldiversityawarenessmonth from Becky Tanamachi, executive director of Manufacturing and Supply Chain Operations.
-
Halozyme, Inc.
@halozymeinc
In honor of Global Diversity Awareness Month, we are highlighting our commitment for equal representation at all levels. We believe that #diversity will optimize the continued growth and success of our company and the biotech industry. Learn more here: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
Our primary technology is based on a proprietary enzyme that degrades hyaluronan (HA) in the subcutaneous space. Learn more about our science and how we use the rHuPH20 enzyme to break down HA: halozyme.com/science/the-role-of-hyaluronan-ha/ha-in-the-…
-
Halozyme, Inc.
@halozymeinc
As #hispanicheritagemonth comes to an end, we continue to honor all of the contributions and traditions Hispanic-Americans have given to our community and the world.
-
Halozyme, Inc.
@halozymeinc
We hope you all are continuing to stay safe and well during this time. For Global Handwashing Day today, we are sharing the importance of handwashing as an effective way to prevent diseases and save lives. Visit our website to read our #covid19 response: halozyme.com/Halozyme-COVID-19-Response/
-
Halozyme, Inc.
@halozymeinc
Hear from Amy Fox, vice president of Human Resources, on our efforts to incorporate diversity and inclusion into the workplace. #globaldiversityawarenessmonth
-
Halozyme, Inc.
@halozymeinc
Today is Metastatic Breast Cancer Awareness Day. Halozyme would like to honor those who are championing and fighting for scientific advances in breast cancer. #breastcancerawareness
-
Halozyme, Inc.
@halozymeinc
Our President & CEO Helen Torley speaks on the importance of #diversity in the biotech industry and how we can continue to foster an inclusive environment. #globaldiversityawarenessmonth
-
Halozyme, Inc.
@halozymeinc
JOIN US NOW - CONSORTIUM Discuss subQ drug development and delivery issues in a pre-competitive manner with the ultimate goal of transforming patient care and improving patient outcomes. Moderator Renee Tannenbaum, PharmD, MBA, CSAP, VP #halozymetherapeutics #podd2020 Day 2
-
Halozyme, Inc.
@halozymeinc
STARTING AT 1:30 pm EST - Consortium members to discuss 5 critical development issues facing the industry, how they are collaboratively working to address these issues, and how interested supporters can get involved. #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020
-
Halozyme, Inc.
@halozymeinc
Is improving patient experiences a key considerations in deciding to develop a subQ drug? Tell us what you think. Take the Rapid Feedback Survey #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020 www.surveymonkey.com/survey-closed/?sm=D8z6Yz1Kh_2BY7BkRV…
-
Halozyme, Inc.
@halozymeinc
REMINDER TODAY 1:30 pm EST - Discuss subQ drug development and delivery issues in a pre-competitive manner with the ultimate goal of transforming patient care and improving patient outcomes. Moderator Renee Tannenbaum, PharmD, MBA, CSAP, VP #halozymetherapeutics #podd2020 Day 2
-
Halozyme, Inc.
@halozymeinc
TODAY 1:30 pm EST Consortium members will discuss 5 critical development issues facing the industry today, how they are collaboratively working to address these issues, and how interested supporters can get involved. #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020
-
Halozyme, Inc.
@halozymeinc
What are the key considerations in deciding to develop a subQ drug? Take the Rapid Feedback Survey #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020 www.surveymonkey.com/survey-closed/?sm=D8z6Yz1Kh_2BY7BkRV…
-
Halozyme, Inc.
@halozymeinc
TODAY 1:30 pm EST CONSORTIUM Discuss subQ drug development and delivery issues in a pre-competitive manner with the ultimate goal of transforming patient care and improving patient outcomes. Moderator Renee Tannenbaum, PharmD, MBA, CSAP, VP #halozymetherapeutics #podd2020 Day 2
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology has a MoA that depolymerizes hyaluronan to help overcome subQ volume limitations. Can it support the development of your subQ formulations? #halozymetherapeutics #podd2020 ONLINE. Email bd4@Halozyme.com to schedule a time to discuss 1-on-1.
-
Halozyme, Inc.
@halozymeinc
One of our core values is: We Respect And Value The Team. This means we build an environment where we work together and help each other achieve common goals. Through this, we are committed to recognizing talent that shares our values. Learn more here: halozyme.com/careers/our-mission/default.aspx
-
Halozyme, Inc.
@halozymeinc
JOIN US NOW: Case Studies in the Development and Commercialization of subQ Biologics Using the #enhanzedrugdeliverytechnology Round Table Discussion with #halozymetherapeutics #podd2020 Agenda Day 1 www.hootsuite.com/error/lost-owly Formulation Technologies.
-
Halozyme, Inc.
@halozymeinc
STARTING AT 3:20 pm: Case Studies in the Development and Commercialization of subQ Biologics Using the #enhanzedrugdeliverytechnology Round Table Discussion with #halozymetherapeutics #podd2020 Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv… Injectable Formulation Technologies.
-
Halozyme, Inc.
@halozymeinc
REMINDER: TODAY at 3:20 pm EST: Case Studies in the Development and Commercialization of subQ Biologics Using the #enhanzedrugdeliverytechnology Round Table Discussion with #halozymetherapeutics #podd2020 Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv… Injectable Formulation Technologies.
-
Halozyme, Inc.
@halozymeinc
JOIN US NOW: Facilitating Rapid Subcutaneous Administration of Large Volume Biologics. Michael J. LaBarre, Ph.D. #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020 Injectable Formulation Technologies Track 1A Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
JOIN US AT 1PM EST: Facilitating Rapid Subcutaneous Administration of Large Volume Biologics. #enhanzedrugdeliverytechnology Michael J. LaBarre, Ph.D. #halozymetherapeutics #podd2020 Injectable Formulation Technologies Track 1A Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
What is the BIGGEST challenge with subQ drug development? Tell us what you think. Take the #halozymetherapeutics #podd2020 Rapid Feedback Survey www.surveymonkey.com/survey-closed/?sm=D8z6Yz1Kh_2BY7BkRV…
-
Halozyme, Inc.
@halozymeinc
REMINDER TODAY 1pm EST -Recent clinical and commercial advances. Overview of #enhanzedrugdeliverytechnology. Michael J. LaBarre, Ph.D. #halozymetherapeutics #podd2020 Injectable Formulation Technologies Track 1A Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
TODAY 1pm EST - Injectable Formulation Technologies Track 1A. Facilitating Rapid Subcutaneous Administration of Large Volume Biologics. Michael J. LaBarre, Ph.D. #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020 Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
Tell Us About Your SubQ Drug Development Needs. Take our Rapid Feedback Survey #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020
-
Halozyme, Inc.
@halozymeinc
TODAY 3:20 pm EST - Injectable Formulation Technologies. Case studies on recently approved products. Learn how #enhanzedrugdeliverytechnology can support the development of subQ formulations. #halozymetherapeutics #podd2020 Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
TODAY 1pm EST - Injectable Formulation Technologies Track 1A. Overview of #enhanzedrugdeliverytechnology including recent clinical and commercial advances. Michael J. LaBarre, Ph.D. #halozymetherapeutics #podd2020 Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
Challenges of traditional subQ & IV drug delivery, like volume limitations, slow delivery speeds and health system costs can be a thing of the past with #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020. Schedule a 1-on-1 partnering session. Email bd4@Halozyme.com
-
Halozyme, Inc.
@halozymeinc
Can #enhanzedrugdeliverytechnology support your drug development? We're breaking traditional volume barriers, enabling bulk fluid flow and increasing dispersion and absorption of subQ administered drugs. #halozymetherapeutics #podd2020 Email bd4@Halozyme.com to schedule a 1-on-1.
-
Halozyme, Inc.
@halozymeinc
On OCT 8 & 9 at #podd2020 ONLINE: Learn how #enhanzedrugdeliverytechnology is clinically and commercially proven to facilitate subQ drug administration. 5-15mL in ~5 min (based on commercially approved products). #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
October is Global Diversity Awareness Month! This month, we are celebrating the diverse minds and beliefs held by all cultures around the world. Together, we are learning more about new cultures and exploring our #diversity.
-
Halozyme, Inc.
@halozymeinc
Ready to transform patient experiences with rapid high-dose, high-volume subQ drug delivery? 5-15mL in ~5 min (based on commercially approved products) #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020 Email bd4@Halozyme.com for a 1-on-1 partnering session to discuss
-
Halozyme, Inc.
@halozymeinc
On Oct 9th, at #podd2020 online, meet the Subcutaneous Drug Development and Delivery Consortium. Our ultimate goal is transforming patient care and improving patient outcomes. Moderator Renee Tannenbaum, PharmD, MBA, CSAP, VP #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Expansion of Collaboration and License Agreement with argenx for ENHANZE® Technology www.prnewswire.com/news-releases/halozyme-announces-expan…
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology is clinically and commercially proven to facilitate subQ drug administration. Schedule a 1-on-1 partnering session at #podd2020 and let's find out. Email bd4@Halozyme.com to schedule a time. #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
Meet our #halozymetherapeutics team at #podd2020. Discover how #enhanzedrugdeliverytechnology may help you develop subQ biologics that transform patient experiences with rapid high-dose, high-volume subQ drug delivery. 5-15mL in ~5 min (based on commercially approved products).
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology has a MoA that depolymerizes hyaluronan to help overcome subQ volume limitations. Can it support the development of your subQ formulations? #halozymetherapeutics #podd2020 ONLINE. Email bd4@Halozyme.com to schedule a time to discuss 1-on-1.
-
Halozyme, Inc.
@halozymeinc
At #podd2020 ONLINE Hear case studies on recently approved #halozymetherapeutics products. Learn how #enhanzedrugdeliverytechnology is clinically & commercially proven to facilitate subQ drug administration.Agenda Day 1 Michael J. LaBarre, PhD Round Table theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
Challenges of traditional subQ & IV drug delivery, like volume limitations, slow delivery speeds and health system costs can be a thing of the past with #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020. Schedule a 1-on-1 partnering session. Email bd4@Halozyme.com
-
Halozyme, Inc.
@halozymeinc
At #podd2020 attend the tech talk online with Michael J. LaBarre, PhD #halozymetherapeutics. Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology. Injectable Formulation Technologies Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
Regular IV treatments currently available to cancer patients can take several hours to administer. At Halozyme, we work with @Biopharma companies to reduce the administration time and potentially improve the patient experience. Learn more here: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
Can #enhanzedrugdeliverytechnology support your drug development? We're breaking traditional volume barriers, enabling bulk fluid flow and increasing dispersion and absorption of subQ administered drugs. #halozymetherapeutics #podd2020 Email bd4@Halozyme.com to schedule a 1-on-1.
-
Halozyme, Inc.
@halozymeinc
On Oct 9th, at #podd2020 online, meet the Subcutaneous Drug Development and Delivery Consortium. Our ultimate goal is transforming patient care and improving patient outcomes. Moderator Renee Tannenbaum, PharmD, MBA, CSAP, VP #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
Ready to transform patient experiences with rapid high-dose, high-volume subQ drug delivery? 5-15mL in ~5 min (based on commercially approved products) #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020 Email bd4@Halozyme.com for a 1-on-1 partnering session to discuss
-
Halozyme, Inc.
@halozymeinc
OCT 8 & 9 at #podd2020 ONLINE: Learn how #enhanzedrugdeliverytechnology may help you develop subQ biologics that transform patient experiences with rapid high-dose, high-volume subQ delivery. 5-15mL in ~5 min (based on commercially approved products). #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
Don’t forget to stay up to date on all Halozyme news and activity by visiting our virtual newsroom for our most recent corporate updates: halozyme.com/newsroom/news-releases/default.aspx
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology is clinically and commercially proven to facilitate subQ drug administration. Schedule a 1-on-1 partnering session at #podd2020 and let's find out. Email bd4@Halozyme.com to schedule a time. #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
On Oct 9th, at #podd2020 online, meet the Subcutaneous Drug Development and Delivery Consortium. Our ultimate goal is transforming patient care and improving patient outcomes. Moderator Renee Tannenbaum, PharmD, MBA, CSAP, VP #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
The #enhanzedrugdeliverytechnology has a MoA that depolymerizes hyaluronan to help overcome subQ volume limitations. Can it support the development of your subQ formulations? #halozymetherapeutics #podd2020 ONLINE. Email bd4@Halozyme.com to schedule a time to discuss 1-on-1.
-
Halozyme, Inc.
@halozymeinc
At #podd2020 ONLINE Hear case studies on recently approved #halozymetherapeutics products. Learn how #enhanzedrugdeliverytechnology is clinically & commercially proven to facilitate subQ drug administration.Agenda Day 1 Michael J. LaBarre, PhD Round Table theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
Challenges of traditional subQ & IV drug delivery, like volume limitations, slow delivery speeds and health system costs can be a thing of the past with #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020. Schedule a 1-on-1 partnering session. Email bd4@Halozyme.com.
-
Halozyme, Inc.
@halozymeinc
Meet our #halozymetherapeutics team at #podd2020. Discover how #enhanzedrugdeliverytechnology may help you develop subQ biologics that transform patient experiences with rapid high-dose, high-volume subQ drug delivery. 5-15mL in ~5 min (based on commercially approved products).
-
Halozyme, Inc.
@halozymeinc
In case you missed it: Our vice president of global partnering, Renee Tannenbaum, is a finalist for the 2020 National Xconomy Awards in the Secret Weapon category. Winners will be announced tomorrow. Best of luck, Renee! www.bioxconomy.com/national-awards/2020-finalists
-
Halozyme, Inc.
@halozymeinc
Can #enhanzedrugdeliverytechnology support your drug development? We're breaking traditional volume barriers, enabling bulk fluid flow and increasing dispersion and absorption of subQ administered drugs. #halozymetherapeutics #podd2020 Email bd4@Halozyme.com to schedule a 1-on-1.
-
Halozyme, Inc.
@halozymeinc
At #podd2020 attend the tech talk online with Michael J. LaBarre, PhD #halozymetherapeutics. Learn about facilitating rapid subQ administration of large volume biologics with #enhanzedrugdeliverytechnology. Injectable Formulation Technologies Agenda Day 1 theconferenceforum.org/conferences/partners-in-drug-deliv…
-
Halozyme, Inc.
@halozymeinc
Ready to transform patient experiences with rapid high-dose, high-volume subQ drug delivery? 5-15mL in ~5 min (based on commercially approved products) #enhanzedrugdeliverytechnology #halozymetherapeutics #podd2020 Email bd4@Halozyme.com for a 1-on-1 partnering session to discuss
-
Halozyme, Inc.
@halozymeinc
On OCT 8 & 9 at #podd2020 ONLINE: Learn how #enhanzedrugdeliverytechnology is clinically and commercially proven to facilitate subQ drug administration. 5-15mL in ~5 min (based on commercially approved products). #halozymetherapeutics
-
Halozyme, Inc.
@halozymeinc
Can #enhanzedrugdeliverytechnology support your drug development? We're breaking traditional volume barriers, enabling bulk fluid flow and increasing dispersion and absorption of subQ administered drugs. #halozymetherapeutics #podd2020 Email bd4@Halozyme.com to schedule a 1-on-1.
-
Halozyme, Inc.
@halozymeinc
Meet our #halozymetherapeutics team at #podd2020. Discover how #enhanzedrugdeliverytechnology may help you develop subQ biologics that transform patient experiences with rapid high-dose, high-volume subQ drug delivery. 5-15mL in ~5 min (based on commercially approved products).
-
Halozyme, Inc.
@halozymeinc
Today is World Patient Safety Day – aimed at enhancing the global understanding of patient safety. At Halozyme, we are committed to the development of therapies with patient safety and benefits in mind.
-
Halozyme, Inc.
@halozymeinc
Listen to our vice president of Global Partnering, Renee Tannenbaum, speak with @dslevine on The Bio Report podcast this week regarding our strategic collaborations with pharmaceutical companies. thebioreport.com/2020/09/17/transforming-infused-biologic…
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Poster Presentation Of Data From Roche's Phase 1b Study Evaluating Atezolizumab For Subcutaneous Administration Utilizing Enhanze® In Non-Small Cell Lung Cancer www.prnewswire.com/news-releases/halozyme-announces-poste…
-
Halozyme, Inc.
@halozymeinc
Today marks the beginning of #hispanicheritagemonth! Our team would like to recognize and celebrate the many contributions, diverse cultures, and extensive histories of the Hispanic-American community.
-
Halozyme, Inc.
@halozymeinc
Today Renee Tannenbaum, our vice president of global partnering, will be speaking as a finalist for the 2020 National @Xconomy Awards in the Secret Weapon category. Tune in at 11 a.m. ET! Register here: xconomy.bioprocessintl.com/national-xconomy-awards-regist…
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Janssen submission for FDA Approval of DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj) for the Treatment of Patients with Light Chain (AL) Amyloidosis www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
We value equal representation at all levels of our company. Did you know that half of our company’s leadership, senior director level and above, are women? Learn more here: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PRESENT AT UPCOMING VIRTUAL INVESTOR CONFERENCES www.prnewswire.com/news-releases/halozyme-to-present-at-u…
-
Halozyme, Inc.
@halozymeinc
Don’t forget to register for the National @Xconomy Awards: Meet the Finalists! Our vice president of global partnering, Renee Tannenbaum, will be featured on Thursday, Sept. 10 at 11 a.m. ET in the Secret Weapon category. Learn more and register here: xconomy.bioprocessintl.com/national-xconomy-awards-regist…
-
Halozyme, Inc.
@halozymeinc
In case you missed it: Last month,@FierceBiotech’s @amirahalidrus wrote a feature on our journey to profitability. Read full article here: www.fiercebiotech.com/biotech/life-after-r-d-death-halozy…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PARTICIPATE IN 2020 WELLS FARGO VIRTUAL HEALTHCARE CONFERENCE www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
Are you looking to partner your program with our drug delivery technology? For more information on partnering with Halozyme, please contact a member of the business development team here: halozyme.com/partnering/opportunities/default.aspx
-
Halozyme, Inc.
@halozymeinc
Congratulations to our VP of Global Partnering Renee Tannenbaum on her selection as a 2020 National @Xconomy Awards Secret Weapon finalist! Under her leadership, we are able to drive forward our mission to build strategic partnerships and improve patient experiences and outcomes.
-
Halozyme, Inc.
@halozymeinc
Happy Women’s Equality Day! Today marks the 100th anniversary of the ratification of the 19th Amendment, which gave women the right to vote in America. Halozyme proudly supports #equality in the workplace and beyond. #womensequalityday
-
Halozyme, Inc.
@halozymeinc
One of our core values is: We Do the Right Thing. This means we are committed to acting with integrity and honesty to uphold the highest ethical standards and build strong relationships with quality work. Learn more here: halozyme.com/careers/our-mission/default.aspx
-
Halozyme, Inc.
@halozymeinc
This week, we are spotlighting Michael J. LaBarre, senior vice president, chief technical officer, who is responsible for providing scientific and technical leadership across all Halozyme programs, including our ENHANZE® drug delivery technology.
-
Halozyme, Inc.
@halozymeinc
Yesterday, our team was privileged to hear from Kelly McCoy, who talked about life before and after her diagnosis of chronic inflammatory demyelinating polyneuropathy.
-
Halozyme, Inc.
@halozymeinc
We value and celebrate the unique talents, backgrounds and perspectives each employee brings to the workplace. If you are interested in the opportunity to work with top tier professionals, view our open positions here: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs
-
Halozyme, Inc.
@halozymeinc
Halozyme Reports Significant Recent Achievements and Second Quarter 2020 Results www.prnewswire.com/news-releases/halozyme-reports-signifi…
-
Halozyme, Inc.
@halozymeinc
Stay up to date on all Halozyme news and activity by visiting our virtual newsroom for our most recent corporate updates: halozyme.com/newsroom/news-releases/default.aspx
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PRESENT AT CANACCORD GENUITY 40TH ANNUAL GROWTH CONFERENCE www.prnewswire.com/news-releases/halozyme-to-present-at-c…
-
Halozyme, Inc.
@halozymeinc
We value #diversity in all aspects of our business operations & continue to build a diverse team who is passionate about having a positive impact on the lives of patients around the world. Learn more about our diversity and inclusion principles here: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
Our ENHANZE® technology has improved #drugdelivery by reducing standard infusion times from hours to minutes and improving patient experiences. Learn more about how we use our unique enzyme to break down HA in the subcutaneous space: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO HOST SECOND QUARTER 2020 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL www.prnewswire.com/news-releases/halozyme-to-host-second-…
-
Halozyme, Inc.
@halozymeinc
Did you know that some cancer patients endure regular IV treatments that can take several hours to administer at a hospital or infusion center? Learn more about how we’re working with #biopharma companies to reduce infusion times: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
Stay up to date on all Halozyme corporate presentations. Check out our most recent webcasts & events on our website: halozyme.com/newsroom/events-and-webcasts/default.aspx
-
Halozyme, Inc.
@halozymeinc
Thanks to our employees, Halozyme recently delivered a car load of school supplies to The Boys & Girls Clubs of Greater San Diego @BGCGSD during their Back 2 School supply drive! #wearehalozyme
-
Halozyme, Inc.
@halozymeinc
This week, we are spotlighting Steve Knowles, our chief medical officer, who plays an instrumental role in serving patients with our ENHANZE® technology by optimizing the way they receive treatment.
-
Halozyme, Inc.
@halozymeinc
In partnership with @OpGratitude, Halozyme team members stuffed more than 400 Battalion Buddies who will soon find new homes with children of deployed service members! #wearehalozyme #virtualvolunteerism
-
Halozyme, Inc.
@halozymeinc
Are you interested in the opportunity to work with professionals to improve subcutaneous drug delivery? Halozyme is looking for top-tier talent. View open positions here: halozyme.wd1.myworkdayjobs.com/halozymecareers/jobs #hiring
-
Halozyme, Inc.
@halozymeinc
One of our core values is: We Focus on the Patients. This means we are committed to providing patients with improved treatment experiences by working with healthcare professionals to design products that optimize the patient experience. Learn more here: halozyme.com/careers/our-mission/default.aspx
-
Halozyme, Inc.
@halozymeinc
We hope you all are continuing to stay safe and well during this time. Visit our website to read more information on our #covid19 response halozyme.com/Halozyme-COVID-19-Response/
-
Halozyme, Inc.
@halozymeinc
Last month, our President & CEO Helen Torley spoke on a panel at #biodigital where she, alongside a panel of experts, discussed the importance of #diversity and inclusion in the #biotech industry.
Listen to the full panel here: #icymi convention.bio.org -
Halozyme, Inc.
@halozymeinc
Last week, we announced that @Roche received #fda approval of a subcutaneous formulation using Halozyme’s ENHANZE® technology.
Read more about the news here: #icymi #drugdelivery halozyme.com/investors/news-releases/news-release-details… -
Halozyme, Inc.
@halozymeinc
Happy Fourth of July from the Halozyme team. We are wishing you a happy and safe holiday!
-
Halozyme, Inc.
@halozymeinc
We are proud to build partnerships through our ENHANZE® drug delivery platform. With the recent news of our 5th partnered product approval, we wanted to share a look at where we are and where we are going.
-
Halozyme, Inc.
@halozymeinc
Today our partner @Roche received FDA approval of a subcutaneous formulation using Halozyme’s ENHANZE® drug delivery technology. Read more about the news here: halozyme.com/investors/news-releases/news-release-details…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES ROCHE RECEIVES FDA APPROVAL FOR PHESGOTM (FIXED-DOSE COMBINATION OF PERJETA® AND HERCEPTIN® FOR SUBCUTANEOUS INJECTION) UTILIZING HALOZYME’S ENHANZE® TECHNOLOGY FOR THE TREATMENT OF PATIENTS WITH HER2-POSITIVE B www.prnewswire.com/news-releases/halozyme-announces-roche…
-
Halozyme, Inc.
@halozymeinc
We have been able to revolutionize the subcutaneous drug delivery space with our ENHANZE® technology, reducing standard infusion times from hours to minutes and improving patient experiences. Learn more about our #drugdelivery platform here: halozyme.com/enhanze/overview/default.aspx
-
Halozyme, Inc.
@halozymeinc
We believe that #diversity in all aspects of business operations will optimize the continued growth and success of our company and the biotechnology industry. Learn more about our diversity and inclusion principles here: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO RECEIVE $10 MILLION MILESTONE PAYMENT FROM JANSSEN www.prnewswire.com/news-releases/halozyme-to-receive-10-m…
-
Halozyme, Inc.
@halozymeinc
At Halozyme, we are working hard to improve patient outcomes with our patient-centered approach to subcutaneous drug delivery through collaborative partnerships.
Learn more about our partnerships here: halozyme.com/partnering/enhanze-technology-partners/defau… -
Halozyme, Inc.
@halozymeinc
This week, we are spotlighting Renee Tannenbaum, our VP of Global Partnering, who is responsible for business development and the overall relationships for all strategic alliances with our ENHANZE® technology, our drug delivery technology intended to improve patient experiences.
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Findings from Janssen's Phase 3 ANDROMEDA Study Evaluating Subcutaneous Daratumumab Utilizing ENHANZE® in Light-chain Amyloidosis Presented at European Hematology Association 25th Annual Congress www.prnewswire.com/news-releases/halozyme-announces-findi…
-
Halozyme, Inc.
@halozymeinc
Today is the day! Don’t miss out on hearing our President & CEO Helen Torley speak at #biodigital to give practical advice for raising up diverse perspectives in biotech. The panel begins at 4:30 p.m. PST: convention.bio.org #diversity #inclusion
-
Halozyme, Inc.
@halozymeinc
Are you registered for #biodigital? If so, don’t forget to tune into the panel titled “Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives” to hear from our President & CEO Helen Torley along with other experts in the industry. convention.bio.org
-
Halozyme, Inc.
@halozymeinc
Yesterday's approval highlights Janssen’s commitment to gaining a better understanding of the evolving needs of people living with multiple myeloma, and to the development of new innovations, combinations, and formulations to best meet those needs. www.businesswire.com/news/home/20200604005487/en/European…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES JANSSEN RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR SUBCUTANEOUS DARZALEX® UTILIZING HALOZYME’S ENHANZE® TECHNOLOGY FOR THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
Next week is #biodigital! Our President & CEO Helen Torley will be speaking on a panel to discuss #diversity and #inclusion in the industry. Learn more and register here: convention.bio.org
-
Halozyme, Inc.
@halozymeinc
Learn more about how we use our proprietary rHuPH20 enzyme to break down hyaluronan (HA) in the #subcutaneous space: halozyme.com/science/the-role-of-hyaluronan-ha/ha-in-the-… #drugdelivery #subq
-
Halozyme, Inc.
@halozymeinc
We have value-driving partnerships with leading #pharma and #biotech companies for our ENHANZE® drug delivery technology. To learn more about our partners and business development opportunities, visit our partnering page: halozyme.com/partnering/enhanze-technology-partners/defau… #drugdelivery
-
Halozyme, Inc.
@halozymeinc
HYLENEX® recombinant (hyaluronidase human injection) and ENHANZE® drug delivery technology are based on our proprietary recombinant human hyaluronidase PH20 enzyme (rHuPH20). Learn more about our #enzyme here: halozyme.com/science/our-technology/rhuph20-overview/defa… #drugdelivery
-
Halozyme, Inc.
@halozymeinc
Did you know that half of our company’s leadership, senior director level and above, are women? Learn more about how we prioritize #diversity and #inclusion here: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
Halozyme to Receive $15 Million Milestone Payment from Janssen www.prnewswire.com/news-releases/halozyme-to-receive-15-m…
-
Halozyme, Inc.
@halozymeinc
We are working to remove the traditional limitations on administering therapies. Learn more about our ENHANZE® drug delivery technology here: halozyme.com/enhanze/overview/default.aspx #drugdelivery
-
Halozyme, Inc.
@halozymeinc
Halozyme Reports First Quarter 2020 Results www.prnewswire.com/news-releases/halozyme-reports-first-q…
-
Halozyme, Inc.
@halozymeinc
Our primary technology is based on a proprietary #enzyme that locally degrades hyaluronan (HA) in the subcutaneous space. Learn more here: halozyme.com/science/our-technology/rhuph20-overview/defa…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PRESENT AT THE BANK OF AMERICA SECURITIES 2020 HEALTHCARE CONFERENCE www.prnewswire.com/news-releases/halozyme-to-present-at-t…
-
Halozyme, Inc.
@halozymeinc
Friday we announced that Janssen received FDA approval of a subcutaneous formulation using Halozyme’s ENHANZE® technology. Read more about the news here: halozyme.com/investors/news-releases/news-release-details….
-
Halozyme, Inc.
@halozymeinc
We value and celebrate the unique talents, backgrounds and perspectives each employee brings to the #workplace. Learn more about how our #diversity and inclusion principles foster a supportive environment for all: halozyme.com/about/Diversity-and-Inclusion/default.aspx
-
Halozyme, Inc.
@halozymeinc
Hear from Halozyme president and CEO Helen Torley on the future of our ENHANZE® drug delivery platform.
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO HOST FIRST QUARTER 2020 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL www.prnewswire.com/news-releases/halozyme-to-host-first-q…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES JANSSEN SUBMITS NEW DRUG APPLICATION IN JAPAN FOR DARATUMUMAB SUBCUTANEOUS FORMULATION UTILIZING HALOZYME’S ENHANZE® TECHNOLOGY FOR PATIENTS WITH MULTIPLE MYELOMA www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
We are proud to have partnerships with pharmaceutical and biotechnology companies of varying sizes and in a range of therapeutic areas. To learn more about our partners and business development opportunities, visit our partnering page: halozyme.com/partnering/enhanze-technology-partners/defau…
-
Halozyme, Inc.
@halozymeinc
We hope you all are staying safe and well during this time. We have placed information on our #covid19 response on our website. halozyme.com/Halozyme-COVID-19-Response/
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES CHANGE OF LOCATION OF ANNUAL STOCKHOLDERS’ MEETING www.prnewswire.com/news-releases/halozyme-announces-chang…
-
Halozyme, Inc.
@halozymeinc
Halozyme Therapeutics to Present at the Cowen 40th Annual Health Care Conference www.prnewswire.com/news-releases/halozyme-therapeutics-to…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES FDA HAS ACCEPTED BIOLOGICS LICENSE APPLICATION FOR FIXED-DOSE SUBCUTANEOUS COMBINATION OF PERJETA® AND HERCEPTIN® USING ENHANZE® TECHNOLOGY www.prnewswire.com/news-releases/halozyme-announces-fda-h…
-
Halozyme, Inc.
@halozymeinc
HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS www.prnewswire.com/news-releases/halozyme-reports-fourth-…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES CFO TRANSITION www.prnewswire.com/news-releases/halozyme-announces-cfo-t…
-
Halozyme, Inc.
@halozymeinc
Halozyme To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call www.prnewswire.com/news-releases/halozyme-to-host-fourth-…
-
Halozyme, Inc.
@halozymeinc
HALOZYME PROVIDES 2020 BUSINESS UPDATE AND FINANCIAL GUIDANCE www.prnewswire.com/news-releases/halozyme-provides-2020-b…
-
Halozyme, Inc.
@halozymeinc
HALOZYME THERAPEUTICS TO PRESENT AT THE 38TH ANNUAL
J.P. MORGAN HEALTHCARE CONFERENCE www.prnewswire.com/news-releases/halozyme-therapeutics-to… -
Halozyme, Inc.
@halozymeinc
Today is World Pancreatic Cancer Day! We’re proud to support the @worldpcc to raise awareness about the symptoms and risks of pancreatic cancer and the urgent need for earlier diagnosis. To learn more, visit www.worldpancreaticcancerday.org and @worldpancreatic. #wpcd #demandbetter
-
Halozyme, Inc.
@halozymeinc
HALOZYME REPORTS THIRD QUARTER 2019 RESULTS www.prnewswire.com/news-releases/halozyme-reports-third-q…
-
Halozyme, Inc.
@halozymeinc
HALOZYME REPORTS THIRD QUARTER 2019 RESULTS www.prnewswire.com/news-releases/halozyme-reports-third-q…
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces Actions to Focus Strategy on ENHANZE® Drug Delivery Technology www.prnewswire.com/news-releases/halozyme-announces-actio…
-
Halozyme, Inc.
@halozymeinc
Halozyme Announces HALO-301 Phase 3 Study Fails to Meet Primary Endpoint www.prnewswire.com/news-releases/halozyme-announces-halo-…
-
Halozyme, Inc. reposted
#WPCD
@worldpancreatic
.@jeopardy host Alex Trebek joins the global movement to raise awareness of the risks and symptoms of #pancreaticcancer for #wpcd. Thank you for your support, Alex! We’re sending you our thoughts as you fight this disease. #demandbetter
-
Halozyme, Inc.
@halozymeinc
Halozyme continued its partnership with @PanCAN at this year’s PurpleStride event – see the video for some of the day’s highlights.
This media couldn't be displayed. See it on the original post. -
Halozyme, Inc.
@halozymeinc
HALOZYME TO HOST THIRD QUARTER 2019 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL www.prnewswire.com/news-releases/halozyme-to-host-third-q…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PARTICIPATE IN 2019 CANTOR GLOBAL HEALTHCARE CONFERENCE www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
Positive Results Announced from Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination of Perjeta® and Herceptin® using Halozyme’s ENHANZE® Drug Delivery Technology www.prnewswire.com/news-releases/positive-results-announc…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PARTICIPATE IN 2019 WELLS FARGO HEALTHCARE CONFERENCE www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
HALOZYME REPORTS SECOND QUARTER 2019 RESULTS www.prnewswire.com/news-releases/halozyme-reports-second-…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PARTICIPATE IN 39TH ANNUAL CANACCORD GENUITY GROWTH CONFERENCE www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
Halozyme To Host Second Quarter 2019 Financial Results Webcast and Conference Call www.prnewswire.com/news-releases/halozyme-to-host-second-…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES JANSSEN SUBMITS EXTENSION APPLICATION TO EUROPEAN MEDICINES AGENCY FOR SUBCUTANEOUS FORMULATION OF DARZALEX® UTILIZING ENHANZE® TECHNOLOGY www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
Halozyme announces first clinical dosing in argenx’s phase 1 trial of efgartigimod (ARGX-113) with ENHANZE® Drug Delivery Technology www.prnewswire.com/news-releases/halozyme-announces-first…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES JANSSEN SUBMITS BLA TO FDA FOR SUBCUTANEOUS FOMULATION OF DARZALEX® UTILIZING ENHANZE® TECHNOLOGY www.prnewswire.com/news-releases/halozyme-announces-janss…
-
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES CRADA WITH NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES FOR USE OF ENHANZE® DRUG DELIVERY TECHNOLOGY www.prnewswire.com/news-releases/halozyme-announces-crada…
-
Halozyme, Inc.
@halozymeinc
Congratulations to @CanaleComm CEO Carin Canale-Theakston for being honored as a 2019 San Diego Entrepreneur of the Year! #eoysd
www.globenewswire.com/news-release/2019/06/07/1865995/0/e… -
Halozyme, Inc.
@halozymeinc
HALOZYME ANNOUNCES ARGENX HAS SELECTED SECOND TARGET UNDER ENHANZE® TECHNOLOGY COLLABORATION AND LICENSE AGREEMENT www.prnewswire.com/news-releases/halozyme-announces-argen…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PARTICIPATE IN BANK OF AMERICA MERRILL LYNCH HEALTH CARE CONFERENCE 2019 www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
Halozyme Reports First Quarter 2019 Results www.prnewswire.com/news-releases/halozyme-reports-first-q…
-
Halozyme, Inc.
@halozymeinc
HALOZYME NAMES DR. ALISON A. ARMOUR AS SENIOR VICE PRESIDENT OF RESEARCH AND DEVELOPMENT www.prnewswire.com/news-releases/halozyme-names-dr-alison…
-
Halozyme, Inc.
@halozymeinc
Halozyme’s CEO, Dr. Helen Torley, writes for @endpts on the importance of diverse and inclusive teams and workplaces. Find out more in this article: endpts.com/the-right-mix-matters-in-biopharma-leadership/
-
Halozyme, Inc.
@halozymeinc
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO HOST FIRST QUARTER 2019 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL www.prnewswire.com/news-releases/halozyme-to-host-first-q…
-
Halozyme, Inc.
@halozymeinc
HALOZYME TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES www.prnewswire.com/news-releases/halozyme-to-participate-…
-
Halozyme, Inc.
@halozymeinc
HALOZYME REPORTS FOURTH QUARTER AND FULL-YEAR 2018 RESULTS www.prnewswire.com/news-releases/halozyme-reports-fourth-…






































































































































































































































































































































































































































































































